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ABSTRACT 
One of the major impediments in the development of marine natural products is the 
provision of biologically active natural products in sufficient quantity for complete 
pharmacological evaluation, clinical h'ials and eventual commercial production. Marine 
microorganisms show great promise in providing a renewable source of biologically active 
natural products. The main aim of this study was to develop and evaluate methods for the 
isolation, identification and cultivation of marine fungi from the South African marine 
environment for the production of biologically active secondary metabolites. 
Twenty-four species of fungi were isolated from marine algae collected from the intertidal 
zone near Port Alfred, South Africa. The fungi were cultivated in small-scale under static 
and agitated conditions and their crude intra- and extracellular organic extracts were 
screened by ' H NMR and a series of bioassays. Using this as a basis, one isolate was selected 
for further study. By analyses of the lTSl region of the ribosomal DNA, the fungal isolate 
was identified as a marine-derived isolate of Eurotium rubrum (Aspergillus ruber). Although 
E. rubrum has been isolated from the marine environment, no investigations have been 
undertaken to determine the adaptation of these isolates to the marine environment. 
In order to optimise productivity, creativity and incubation time, the fungus was cultivated 
in small-scale using a variety of carbon (glucose, fructose, lactose, sucrose, marmitol and 
maltose) and nitrogen sources (ammonium tartrate, urea, peptone and yeast extract). An 
HPLC-DAD method was developed to assess the metabolic creativity and productivity 
under different fermentation conditions. Distinctive variations in the range and yield of 
metabolites produced as well as morphology and growth time were observed. 
111 
The crude extracts from all fermentations were combined and six known compounds 
were isolated by reversed-phase chromatography and their structures elucidated by 
spectroscopic techniques . The known compounds were fIavoglaucin, aspergin, 
isodihydroauroglaucin, isotetrahydroauroglaucin, neoechinuline A and physcion. 
Neoechinuline A, isodihydroauroglaucin and isotetrahydroauroglaucin showed activity 
against oesophageal and cervical cancer cell lines. 
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Chapter 1: Review of Literature 
Microorganisms have rapidly gained resistance to antibiotics due to the inappropriate use of 
these drugs. Consequently, what was once considered a routine infection can now become 
fatal. For example, enterococci, traditionally regarded as low-grade pathogens, are now the 
third most common cause of nosocomial infections in the United States. In 1941, virtually all 
strains of Staphylococcus aureU5 were sensitive to penicillin G. By 1992, 95% of these strains 
were antibiotic resistant. Even the primary drug of the last resort for methicillin-resistant S. 
aureU5, the glycopeptide vancomycin, has been rendered ineffective in at least three cases 
(Jensen and Fenical, 2000). 
In addition to microbial pathogens, genetic diseases such as cancer continue to be of concern 
in the 21" century. Currently, the treatment of cancers still involves surgery, radiation and 
chemotherapy. Chemotherapy has been one of the major therapeutic methods commonly 
used as treatment for a variety of cancers (Han et a/., 1998). However, in many cases, 
chemotherapy alone cannot achieve a satisfactory therapeutic outcome, namely the complete 
remission of tumours and prevention of metastasis. In addition, it is difficult to protect 
healthy cells from the harmful effects of cancer treatment which induces severe side-effects 
at therapeutically effective doses (Sallager and Lodge, 1998). The side-effects mainly depend 
on the type and extent of the treatment. Some anticancer drugs can cause side-effects such 
as loss of fertility, nausea, diarrhea, loss of hair and the reduction of white and red blood 
cells and platelets. Due to this there is a desperate need for new and improved drugs on the 
market. 
1.1 Drug Discovery and Natural Products Chemistry 
There are three main approaches for searching for drugs in a drug discovery programme: 
a) Rational Drug Design: Using bioinformatics and molecular modeling drugs are designed 
to target specific receptors in cells. 
b) Synthetic and Combinatorial Chemistry: Manipulating an existing drug or natural 
product to improve on its pharmacological profile. 
c) Natural Product Programme and Combinatorial Biosynthesis: Screening natural products 
for pharmacological activity and the use of protein/ gene engineering to alter biosynthetic 
pathways thus increasing natural product diversity. 
The most successful strategy thus far in finding new drugs has proven to be through natural 
products research. Natural products, or secondary metabolites, have been exploited by man 
for a variety of purposes including its use as food, fragrances, pigments, insecticides and 
2 
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medicines. Historically, plants have served as a major source of medicinally useful natural 
products, developed from a legacy of folk medicine based on herbal remedies (Carte, 1993). 
The first hymns of the Sanskrit text Artharva-veda Samilita, (-2100 BC) mention destroying 
"invisible worms" in the body and suggest using a plant growing on the tree (fungus or 
lichen) to cure infections (Galperin and Koonin, 1990). Since then humans have been 
utilising various naturally occurring chemical substances with biological activity. Even with 
the advent of combinatorial chemish·y, molecular biology and high throughput screening 
(HTS), the use of natural products has been the single most successful strategy for the 
discovery of new medicines (Nisbet and Moore, 1997; Bindseil et aI, 2001). It is unlikely that 
rational drug design would have produced many of the complex structures of the 
therapeutically useful natural products (Lawrence, 1999). 
Important natural product derived drugs include cyclosporin, avermectin (antiparasitic), 
taxol and camptothecin derivatives, (anticancer), erythromycin (antibiotic) and lovastatin 
derivatives (hypercholesterolaemic agents) (Nisbet and Moore, 1997; Bindseil et aI, 2001). 
Towards the end of the 1980's, approximately 75% of the top 20 hospital drugs and 20% of 
the top 100 most w idely prescribed drugs were derived from natural sources. These mostly 
included antibiotics from microbial fermentation broths and alkaloids from plants 
(McConell, 1994). Therefore due to their success, natural products are likely to continue as a 
source of commercially viable drug leads. 
Despite the enormous structural diversity, Nature only uses a few basic building blocks. 
These are acetate, mevalonic acid and shikimic acid. The acetate unit is used in polyketide 
biosynthesis, while mevalonic acid leads to all terpenoids. However, a mevalonic acid 
independent pathway - leading to terpenes is well established in bacteria (Eisenreich et a/., 
1998; Rohmer, 1999; Lichtenthaler, 1999). Shikimic acid leads to the synthesis of aromatic 
amino acids, cinnamic acids, lignin and lignans. The structural diversity found in natural 
products results from various enzymes found in each species that introduce new 
functionalities, such as hydroxyl, epoxy and methoxy groups (Verpoorte, 2000) . Table 1.1 
shows the major classes of known natural products and clearly illustrates that the terpenoids 
-and the alkaloids are the most abundant. The latter group in particular contains a large 
number of drugs due to their special characteristic of being water-soluble under acidic 
conditions and having lipophilic properties under neutral and basic conditions (Verpoorte, 
2000) . 
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Table 1.1: Number of Secondary Metabolites from all Organisms in the "Dictionary of 
Natural Products" (Verpoorte 2000) , 
Metabolites Number 
Aliphatics 5950 
Poly ketides 2753 
Carbohydrates 3397 
Oxygen Heterocycles 1484 
Simple Aromatics 5041 
Benzofuranoids 444 
Benzopyrenoids 2859 
Flavanoids 8405 
Tannins 783 
Lignans 1729 
Polycyclic Aromatics 2621 
Terpenoids 30500 
Amino acids, Pep tides 4303 
Alkaloids 16833 
While some scientists view natural products as "waste products", others propose that they 
are produced to provide an advantage to the organism or would have once served a role. 
Faulkner (2000) hypothesised that organisms that do not contain sophisticated immune 
systems use natural products or allelochemicals, in response to a variety of ecological, 
behavioural and physiological factors. In order to survive and reproduce in their 
environments, sessile organisms must produce compounds that are used to chemically 
defend themselves and! or to assist in the prevention of overgrowth or fouling because they 
lack physical defenses. This view was acknowledged by da Rocha et aI., (2001) who 
suggested that organisms evolve due to a selective advantage they obtain as a result of 
interactions of the natural products with specific receptors in other organisms. Firn and 
Jones (2003) have recently developed a new model to explain (1) why there is chemical 
diversity, (2) how it is generated and (3) how it is maintained although there may not be any 
direct role for the compound. Their hypothesis is that organisms produce a diversity of 
compounds to increase their chances of producing a compound with potent biological 
activity. Those organisms which can reduce their metabolic costs (cost of generating and 
retaining products of no current value) will have an advantage over their competitors. 
These "no value" compounds are produced by multiple pathways and act as intermediates 
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to the final metabolic product, thus increasing the length of the pathway and the metabolic 
diversity. 
Whatever the reasons are for their production, some of these secondary metabolites have 
therapeutic potential against human diseases because of specific interactions with receptors 
and enzymes. According to Harvey (2000) specialised cells such as nervous, immune and 
vascular systems, appeared relatively recently in evolution, while the transmitter molecules 
they use, may have arisen much earlier in unicellular or simple multi-cellular organisms. 
1.2. Marine Natural Products 
Traditional bioprospecting sources, i.e. terrestrial plants and soil microbes, have in recent 
years produced a high percentage of known compounds resulting in a search for new 
natural product sources. There has been a tremendous level of interest in the marine 
environment from both academia and industry because of the extensive speciation at all 
phylogenetic levels, from mammals to microorganisms (Cowan, 1997). This has resulted 
due to extreme variability of physical conditions such as temperatures of between l.5°C to 
350°C, pressures ranging from 1 to over 1000 atmospheres, nutrient variations ranging from 
eutrophic to oligotrophic, and extensive photic and non-photic zones. 
A large number of compounds possessing unique structural features that are not found in 
terrestrial natural products have been isolated from marine SOurces (Carte, 1993; Davidson, 
1995). One of the most obvious differences between terrestrial and marine natural products 
is the frequent incorporation of halogens, particularly bromine into the latter. This is due to 
an adaptation to the marine environment which contains ca. 199.L-l of chloride and 65mg.L-l 
bromide (Thompson, 1978). This is exemplified by the isolation of chloriolins A - C (1.1 -
1.3), from a marine-derived fungus. These compounds are related to coriolin B (1.4) and 
dihydrocoriolin C (1.5), previously isolated from the terrestrial wood rotting fungus Coriolus 
cansors. The marine isolates were different in that the marine-derived coriolin derivatives 
were chlorinated (Davidson, 1995) (Fig. 1.1). 
5 
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O~ 
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O~ 
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1.2:R=OH 
1.3: R = H 
Fig-. 1.1: Coriolins. 
R 
Chloriolin A, Band C isolated from the marine environment. 
Coriolin Band dihydrocoriolin C from a terrestrial fungus. 
1.2.1. Industrial Applications of Marine Natural Products 
Marine natural products have contributed to health-food additives, materials for 
orthopeaedics, enzymes for molecular biology and bioadhesive materials, all of which are in 
the market. According to Bongiorni and Pietra (1996), 80% of all patent applications in this 
area are from the health and health food sector. While drug discovery is dominated by 
antitumoural and antiviral agents (reflecting the most popular screening systems in use), 
materials for bone surgery, immunoregulatory agents, anti-inflammatories and antibiotics 
have also made significant contributions and show potential for commercialism. Table 1.2 
shows some of the commercially available marine bioproducts. 
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Table 1.2: Commercially Available Marine Bioproducts (Bongiorni and Pietra, 1996; 
McCarthy and Wright. 1997; Pomponi, 1999). 
Product 
Arabinosyl-A 
Arabinosyl - C 
Okadaic acid 
Manoalide 
Vent™ DNA polymerase 
Resilience 
(Pseudopterosin C) 
Formulaid 
Trans/cis-~-carotene 
Cartap hydrochloride 
Cell-Tak 
Green Fluorescent Protein 
(GFP) 
Formulaid R 
Application 
Antiviral drug 
Anticancer drug 
Molecular probe, phosphatase 
inhibitor 
Molecular probe phospholipase 
A2 inhibitor 
PCR enzymes 
Cosmetic by Estee Lauder 
Infant food additive 
Food pigment 
Insecticide 
Bioadhesive 
Molecular tool 
Fatty acids, additive in infant 
nuh'itional supplement 
Source 
Marine sponge, 
CnfPtoteth1fa cnlPta 
C. cnjpta 
Dinoflagellate 
Marine sponge, 
Luffariella variabilis 
Deep-sea hydrothermal 
vent bacterium 
Pseudopterogorgia elisabethae 
Crypthecodinium cohnii 
Dunaliella sp. 
Almelid 
Mytilus edulis (mussel) 
Aequorea victoria Uellyfish) 
Marine macroalgae 
Initially research targeted organisms such as gorgonians, sea hares, nudibranchs, sponges, 
molluscs, ascidians, bryozoans, soft corals and algae. Data from the National Cancer 
Institute (NCI), U.s.A (Fig. 1.2) clearly indicate that marine animals display the highest 
incidence of significant cytotoxic activity (Munro et aI., 1999). However many of the 
compounds isolated are produced in small quantities and industrial synthesis is hampered 
because of their complex structures. Thus acquisition of material required for biological 
evaluation has relied on massive collection efforts, a process which, even when possible, is 
time-consuming, expensive and potentially damaging to the fragile reef habitat (Davidson, 
1995; Borris and Gould, 1999; Jensen and Fenical, 2000). No matter how attractive a 
biological profile of a compound may be, unless an adequate supply can be generated for 
testing and thereafter for commercial sales, the compound will not progress on to the next 
step (Munro et al., 1999). The most famous example of a compound in this situation is 
Halichondrin B from Halichondria okadai (Hirata and Uemura, 1986), which is a potent 
antimitotic agent. Due to these bottlenecks, research has turned to marine microorganisms 
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as a source of novel chemicals with therapeutic value as fermentation yields a continuous 
source of material. 
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Fig. 1.2: Distribution of Samples with Significant Cytotoxicity at the NCr's Preclinical 
Screens (Munro et al., 1999). 
1.2.2. Marine Microorganisms 
Since the discovery of penicillin in 1929, intensive studies have shown that microorganisms 
are a rich source of structurally unique bioactive substances. Over 50 000 natural products 
have been discovered from microorganisms of which more than 10 000 of these are 
biologically active and more than 8 000 are antibiotics and antitumour agents (Be tina, 1983; 
Berdy, 1989). Due to this, marine microorganisms, have received increasing attention over 
the past decade. These microorganiSms have been isolated from marine sediments, water 
samples, decaying pieces of drift wood, from marine algae (seaweed) and macroorganisms 
(McConell et al., 1994; Faulkner, 2000). In fact, it has been repeatedly suggested that 
symbiotic microorganisms isolated from macroorganisms are the true source of these 
bioactive metabolites (Faulkner, 2000) . For example, Cyrindramide isolated from a sponge, 
is closely related to the cytotoxic alkaloid alteramide A, produced by the sponge-derived 
Alteromonas sp. (Jensen and Fenical, 2000). 
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1.2.2.1. Marine Fungi 
Kohlmeyer and Kohlmeyer (1979), defined obligate marine fungi as those growing and 
sporulating exclusively in a marine and estuarine habitat. Facultative marine fungi are those 
from freshwater or terrestrial milieus that are able to grow and possibly sporulate in the 
marine environment. Marine fungi that do not germinate in the natural marine habitat are 
not included in this definition. Marine fungi have been poorly investigated. By 1991, only 
321 species of marine mycelial fungi worldwide had been identified, represented by 225 
Ascomycetes, 6 Basidiomycetes and 60 Deutromycetes (Kohlmeyer and Volkmann-
Kohlmeyer,1991). Now with results from ribosomal RNA (rRNA) sequencing, it has been 
predicted that less than 1 % of the naturally occurring microbial diversity has been cultured. 
Conservative estimates also suggest that there are likely to be over 1.5 million fungal species 
(terrestrial and marine), of which less than 5% have been described (Gloer, 1997). 
Marine fungi live as sap robes on algae, driftwood, decaying leaves and other dead organic 
material of plant and animal origin (Davidson, 1995; Libierra and Lindequist, 1995). They 
may also occur as parasites on mangroves, shells, crabs, sponges, fish and plants and are an 
important group of pathogens in the marine world (Libierra and Lindequist, 1995) . Other 
species exist as symbionts in invertebrates and plant material. Fungi have also been found 
on coral reefs (Volkmann-Kohlmeyer and Kohlmeyer, 1992). Among the marine fungi, those 
living in association with marine algae are a particularly promising source of novel natural 
products. Fungi commonly thrive in competitive environments, and it is often hypothesised 
that some of their secondary metabolic capabilities may be influenced by selection pressures 
exerted by other organisms (Gloer, 1997). The association between fungi and algae seems to 
be highly developed since nearly one-third of all higher marine fungi described are so-called 
algicolous or algae-associated organisms (Abdel-Lateff et al., 2002). Fungal representatives 
from all subdivisions of the Eumycota, i.e. Ascomycotina, Deuteromycotina, 
Basidiomycotina, Zygomycotina, and Mastigiomycotina, are found growing on algae 
(Stanley, 1992) . The surfaces of marine algae are good nutrient-rich sources of 
microorganisms e.g. Penicillium sp. was found on En teromorpha intestinalis A, which 
produced the novel polycyclic alkaloids communesins A (1.6) and B (1.7) (Numata et al., 
1993). 
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Fig. 1.3: Communesins A and B. 
1.6: R=CH3 
1.7: R= CH=CH-CH=CH-CH3 
These nitrogen containing heterocyclic compounds also exhibited moderate to potent 
cytotoxic activity in the P-388 lymphocytic leukemia test system with EDso values of 3.5 and 
0.45).lg/ mL, respectively (Libierra and Lindequist, 1995). Another algicolous fungus, 
Wa rdomyces anomalus isolated from Enteromorpha sp. showed antimicrobial effects towards 
Microbotnjum violaceum and Eurotium repens, inhibition of HIV reverse transcriptase and 
inhibition of p56lck tyrosine kinase (Abdel-Lateff et aI., 2003). Hydroquinone derivatives 
from an algicolous Acremonium sp. were also found to have significant antioxidant 
properties (Abdel-Lateff et aI., 2002). 
In comparison with secondary metabolites from other marine organisms such as algae, the 
number of metabolites isolated from marine fungi is small (Libierra and Lindequist, 1995) . It 
has been estimated that less than 1 % of potentially useful chemicals from the marine 
environment have been screened thus far, with microbial products representing 
approximately 1 % of that total number (Colwel, 1993). Of the compounds isolated, the 
predominant activities, have been compounds with antibacterial, antifungal and cytotoxic 
activities (Libierra and Lindequist, 1995). Some of the most popular examples are 
highlighted in Table 1.3. 
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Table 1.3: Some Metabolites Isolated from Marine Fungi 
Fungus Metabolite isolated Reference 
Penicillium sp. Communesins A (1.6) and B (1.7) Davidson, 1995 
Acremo11iu111 sp. Oxepinamide A - C (1.8 - 1.10), Belofsky et al., 2000 
Fumiquinazoline H (1.11) 
SCtjtalidium sp. Exumolidse A (1.12) and B (1.13) Jenkins, 1998 
Aspergillus sp. Chlorocarolide A (1.14) AbreU et al., 1996 
Spirastrella vagabunda 14,15-secocurvularin (1.15) AbreU et al., 1996 
Aspergillus sp. Aspergilloxide (1.16) Cueto et ai., 2002 
Ascoch1jta salicorniae Ascosalipyrrolidinone A (1.17) Osterhage, 2000 
Fusarium sp. Sansalvamide (1 .18) Belofsky et al., 1999 
rOyN~~H 
)=/yN0o oK" 
o C~ 
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1.9: RJ = OH; R2 CH(CH3)CH2-CH3 
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Fig. 1.4: Marine-derived Compounds 
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1.2.3. South African Marine Natural Products 
There are large areas of South Africa's marine environment where biological communities 
are poorly described at the species level due to a shortage of taxonomists (Pauw and 
Durham, 2003). In particular, very few studies on marine microorganisms have been 
undertaken. By 1993, only three research papers on marine fungi collected off the coast of 
South Africa were published. Gorter (1978), collected ten species from the Atlantic coast; 
Jones et al . (1972), collected three species from the Indian Ocean and Kohlmeyer and 
Kohlmeyer, (1971), collected nine species from the Indian Ocean, all mainly from the Durban 
region. Steinke was the only local person researching marine and estuarine fungi up until 
then. His studies concentrated on lignicolous fungi on driftwood. Currently, Coyne at the 
University of Cape Town is involved in the identification and characterisation of marine 
microbes. Thus the southern oceans, in particular the South African marine environment 
poses a promising frontier for the discovery of new therapeutics. 
Like many developing countries, the biodiversity of South Africa provides a very valuable 
resource (Cowan and Burton, 2002). Given that 99% of existing microbial species in any 
environment have not yet been cultured, and that the environmental diversity offers a huge 
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range of microbial habitats, it can be predicted with some confidence that this country 
harbours millions and possibly tens of millions of new microbial genomes. This has not 
escaped the attention of international bioprospecting companies, who have already initiated 
programmes investigating South African biodiversity (Cowan and Burton, 2002). 
1.3. Approaches to Natural Products Drug Discovery 
Natural product drug discovery can be separated into three categories: 
a) Chemically driven: Isolating new chemical entities followed by assessment of biological 
activities for purified compounds 
b) Biologically driven: Bioassay-guided fractionation beginning with crude extracts 
c) Combination of chemically and biologically driven approaches 
The chemically driven approach has been pursued vigorously, primarily by academic 
research groups. The number of compounds found in various reviews attest to the success 
of this approach. Over 1200 pure compounds have been isolated in the laboratories of two 
pioneers in marine natural products chemistry, William Fenical and D. John Faulkner and 
although some of these compounds were isolated based on the antibacterial, cytotoxic 
and/ or anti-inflammatory activities of the respective extracts, many were isolated based on 
purely chemical, chemotaxonomic, or chemical ecological interests (McConell et al., 1994). 
Although most of the approaches are directed towards the effective use of new organisms, 
the most important paradigm shift for natural product chemistry is the general change from 
activity-guided extract screening (although still widely used) to pure-compound screening. 
This is the approach MEGAbolite® has adopted and successfully used (Bindseil et al., 2001). 
The idea to screen extracts from natural sources by neglecting desired biological activities of 
metabolites in the first stage of screening was postulated by Umezawa in the late 1970's and 
further developed by Zahner and co-workers (Bindseil et al., 2001). This approach has been 
mainly adopted by academic institutions because the bioassay-fractionation route requires 
extensive, time-consuming and costly deconvolution. This results from interfering 
substances in the crude extracts which cause false positives. Although there are methods to 
maximise efficiency by dereplication, these require a library of compounds and in-house 
databases which are expensive. In conh'ast, the pure compound screening approach is 
cheaper and permits the isolation of metabolites which can thereafter be screened in various 
bioassays or the activity predicted by sh·ucture-activity-relationships. The disadvantage is 
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that only those compounds which are produced in abundance (> 1mg for structure 
elucidation) can be studied. 
1.4. Bioprospecting 
Bioprospecting is the search for organisms that may potentially serve as a source of natural 
products. Conventional bioprospecting screening programmes search for these natural 
products randomly, h owever nowadays the exploration of metabolites on the basis of 
ecologically sound observations is gaining support. This method provides a more direct 
route to the discovery of useful metabolites (de Nys and Steinberg, 2002). The recent efforts 
of several industrial explorations into the coral reefs i.e. where a large variety of sessile 
organisms populate (Bongionu and Pietra, 1996), has confirmed that hypothesis-based 
studies to be highly lucrative. This type of non-random bioprospecting facilitates 
dereplication and pernUts evaluation of a hypothesis. 
1.5. Bottlenecks in Marine Natural Products/Biotechnology Industry 
There is a need for more effective and rigorous methods of development in marine natural 
products research especially if it is to successfully make a profound impact on the provision 
of drug leads. These areas of concern have been highlighted as: 
a) Bioprospecting: New niches need to be investigated for new species to be studied 
b) Isolation Methods: More effective strategies are needed for the isolation and culturing of 
marine nUcroorganisms 
c) Quick and reliable methods of dereplication of the source organism and of the 
metabolites isolated 
d) OptinUsation of production of metabolites 
e) Faster and simpler techniques are required for extraction, purification and analyses of 
metabolites 
1.6. Aims and Objectives of this Study 
The discussion above has highlighted the need for new drugs and draws attention to some 
of the main problems associated with the discovery of new drug leads from the marine 
environment. It is clear that one of the major challenges for Marine Biotechnology is to 
provide biologically active marine natural products in sufficient quantity for complete 
pharmacological evaluation, clinical h'ials and eventual commercial production. Thus, the 
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main aim of this study was to develop and evaluate methods for the isolation, identification 
and cultivation of marine fungi from the South African marine environment for the 
production of biologically active secondary metabolites . 
Thus, the specific objectives are: 
1. To isolate marine epiphytic and endophytic fungi from seaweed using selective media 
2. To identify fungal isolates using DNA analyses and morphology 
3. To optimise metabolic creativity and productivity 
4. The isolation and structure elucidation of secondary metabolites produced 
5. The bioactivity screening of metabolites 
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Chapter 2: Preliminanj Screening of Secondanj Metabolites from Marine fungi 
2.1. Introduction 
A natural products drug discovery progranune from microorganisms is essentially an 
integrated approach of Microbiology, Biotechnology, Natural Product Chemistry and 
Pharmacology. The first step in the discovery progranune is the isolation of the microbe 
from Nature. This involves selective isolation media to isolate only a certain type of microbe 
e.g. gram positives, gram negatives, fungi etc. Once isolated and purified, the microbe can 
be identified via a number of different methods. The biotechnologist optimises fermentation 
conditions by medium and culture technique development for the production of metabolites 
and the natural product chemist extracts, purifies, identifies and then screens these 
metabolites for potential biological activity. A further crucial aspect of drug discovery is the 
availability of suitable biological assays in order to assess the pharmacological potential of 
isolated natural products. The primary screening of extracts, although essential for 
dereplication and the discovery of samples with "interesting chemistry" can be time 
consuming and costly. 
Fungi associated with marine algae have been proven to be rich sources of microorganisms 
(Burgess et aI., 1999) and several bioactive metabolites have already been isolated from 
algicolous fungi. 
The main objectives of the research presented in this chapter were to: 
(a) Selectively isolate fungi associated with marine algae, 
(b) Cultivate isolated fungi for metabolite production, and 
(c) Screen extracts obtained for "interesting chemistry" and biological activity. 
2.2. Materials and Methods 
2.2.1. General Experimental 
All extraction solvents were redistilled. Deuterated chloroform (CDCh) was used for all1H 
NMR analyses using a Bruker Avance Nuclear Magnetic Resonance Spectrometer (400MHz) 
at 27°C. All media reagents were obtained from Merck. Seawater was obtained from Port 
Alfred and filtered before use. 
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2.2.2. Collection of Marine Macroalgae 
Ten species of red marine macroalgae were collected from the intertidal zone at the Three 
Sisters near Port Alfred on the Eastern Cape coast of South Africa. The seaweeds were 
stored in separate sterile plastic bags at -20°C before inoculating them onto solid media. 
Fig. 2.1: Sampling Site 
2.2.3. Isolation of Fungi 
Two different media were used for the isolation of fungi. These were composed of (a) 0.5% 
yeast extract, 0.5% peptone, 1 % glucose and 1.7% bacteriological agar made up to 1000mL of 
natural sea water (yPG Basal medium) and (b) 1.7% bacteriological agar made up to 1000mL 
sea water (SW A). After autocIavation, the media were supplemented with 75mgjL 
penicillin (penilente-Forte) and 75mgjL streptomycin (Novo-Nordisk) by 0.22pm filter 
sterilisation. 
The seaweeds were rinsed in sterile seawater. Both epiphytes and endophytes were selected 
for, as described by Hunter-Cevera and Belt, (1999). For the selection of epiphytes, the algae 
were cut into 0.5cm3 and embedded into the agar. For the selection of endophytes, the 
surface of the seaweeds were sterilised with 70% ethanol for 5 minutes. The seaweeds were 
then shredded using a sterile blade to expose the inner tissue and inoculated on agar plates. 
As a control for contaminating epiphytes, the unshredded surface-sterilised seaweeds were 
also inoculated. Plates were then incubated at 24°C until fungal growth. All fungi were 
subcultured to fresh solid media to attain pure cultures. 
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2.2.4. Growth Kinetics 
The growth characteristics of the fungi were studied by measuring the absorbance, as 
described by Langvad, (1999). Six mycelial circles (five day cultures) of diameter 7mm were 
cut out from YPG mycelial mats using pasteur pipettes and transferred to 100mL Erlenmeyer 
flasks containing 30mL sterile seawater. The mycelia were homogenised using a Janke and 
Kinkel IKA-Werk Ultra-Turrax blender for 3 x 0.5s bursts. 20)1L of the homogenate and 
180)1L of the YPG medium were used to inoculate Costar 3595 (Promex) 96-weII microtitre 
plates. 20)1L of seawater was added instead of the homogenate for controls. Plates were 
inoculated in triplicate for each isolate and incubated at 24°C. The absorbance was 
measured at 630nm twice daily using a Powerwave X micro titre plate reader. To confirm 
these results, the broth was extracted at the onset of stationary phase to assay for reducing 
sugars using the Somogyi-Nelson Glucose Assay (Appendix A). 
2.2.5. Cultivation of Fungi 
250mL YPG media in 500mL Erlenmeyer flasks were used for static and agitated cultures. 
5 x 0.5cm3 pieces of five day old mycelia maintained on YPG agar were used as inoculum. 
Agitated cultures were shaken on a Labcon flat bed shaker at 125 rpm at 24°C until the onset 
of stationary phase. The onset of stationary phase was identified by the production of 
spores and confirmed by growth kinetic studies. 
2.2.6. Metabolite Extraction 
At the onset of stationary phase (idiophase), the mycelia and broth were separated by 
centrifugation at 10 OOOrpm for 20 minutes. The broth was extracted thrice with 150mL 
EtOAc and dried over Na,SO, (anhydrous). The mycelia were crushed using liquid 
nitrogen, extracted with 100mL MeOH for 2 hours then MeOH/ dichloromethane 
(50mL:50mL) overnight and again with MeOH overnight. The broth and mycelial extracts 
were then dried in vacuo using a Buchi rota vapour RE 120. The crude exh·acts were then 
analysed by 'H NMR and evaluated using a metabolic creativity index. The assignment of 
metabolic indices were based on quantitative measurements i.e. peak numbers and their 
respective chemical shifts. Both the inoculated broth and agar media were used as controls. 
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2.2.7. Brine-shrimp Assay 
Brine-shrimp (Artemia salina) eggs were obtained from PRO 100; Ocean Star, International 
Inc., Utah and hatched in a cone-shaped glass container containing aerated sterile natural 
seawater at 29°C with artificial light for 24 hours. Phototrophic naupli were collected from 
the lightened side by pipette. 
Extracts were dissolved in absolute EtOH (100)1L) with the aid of a sonicator and was used 
to make up a stock solution of 10mg/ mL. 100)1L of this solution was added to 650)1L of 
sterile seawater. 150)1L of the resulting working solution (lmg/750)1L) was used to 
inoculate row A in microtitre plates (Costar 3595, Promex). Serial dilutions were made to 
attain final concentrations of 570rg/mL; 285rg/mL; 142)1g/mL and 71rg/mL. A 
suspension of naupli containing 10-15 organisms (lOOrL) was added to each well. The 
plates were incubated at 29°C with the lids on for 24 hours. Naupli were then examined 
with a dissecting microscope (x12) and the numbers of dead naupli in each well recorded. 
lOOrL of MeOH was added to each well to sacrifice the remaining shrimp and after 20 
minutes the total number of shrimp in each well was counted. All experiments were done in 
duplicate with solvent controls. 
2.2.8. Anti-cancer Assays 
Crystal Violet Cytotoxicity Assay (Appendix A) 
The Cytotoxicity Assay was performed at the Department of Medical Biochemistry, 
University of Cape Town, courtesy of Dr Hendricks. Briefly, compounds were tested at 
concentrations 50rg/mL, lOrg/mL and l)1g/mL 0.2% DMSO against WHC01 (an 
oesophageal cancer cell line) and ME 180 (a cervical cancer cell line) (1500 cells/well) in 
CellStar 96 well microtitre plates. The plates were incubated at 37°C for 48 hours. 
Thereafter the media were replaced with MeOH (10 minutes) and then Crystal Violet 
Solution (20 minutes). The plates were washed for 60 minutes with distilled H20 and then 
read at ODs9s using an Anthos Microtitre Plate Reader. Solvent and media controls were 
included. 
2.2.9. Antibiotic Assays 
The antibiotic tests were performed at Tygerberg Hospital/University of Stellenbosch. The 
surfaces of Mueller Hinton plates were inoculated with 0.5 McFarland turbidity with test 
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organism solutions (1.5 x 108 organisms/mL except for Candida albicans which was 1 x 106 
organisms/mL). These included Pseudomonas aemginosa (ATCC 27853), Staphylococcus aureus 
(ATCC 25923), Escherichia coli (ATCC 25922) C. albicans (#500312) and Klebsiella pneumoniae 
(#055725). All strains were methicillin resistant except for S. aureus. The surfaces were 
allowed to dry, wells were made and 5 and 10JIL of a 100JIg/mL of the extract in saline was 
tested against each organism. Plates were incubated at 28°C. Zones of inhibition were 
checked for after 24 hours. 
2.3. Results and Discussion 
2.3.1. Collection and Identification of Seaweeds 
The following seaweeds (Table 2.1) were identified by Professor Lubke from the Deprutment 
of Botany, Rhodes University. 
Table 2.1: Provisional Identification of Seaweed Collected from the Three Sisters Beach 
Collection no. Provisional Identification 
TS010l Unidentified 
TS0102 Plocamiul7l sp. 
TS0103 Gracilaria backeri 
TS0104 Galaxaura diesingiana 
TS0105 Plocamium corallorhiza 
TS0106 Gigortinn sp. 
TS0107 Unidentified 
TS0108 Cnnjophyllul7l seal are 
TS0109 Sargnssul7l sp. 
TSOnO Epymeria sp. 
2.3.2. Isolation of Fungi from Seaweed 
The seaweeds were collected and stored separately in sterile bags to ensure that cross 
contamination of epiphytic fungi or contamination from the terrestrial environment did not 
occur. Sea Water Agar (SWA) medium, which is a nutrient poor medium, is only composed 
of seawater, containing trace elements and cell debris, and agar (a carbohydrate source). 
Therefore this medium permits the growth of fungi which are slower growing. In contrast, 
YPG medium is a high nutrient medium and supports the growth of fastidious fungi 
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because these out-compete the slower growing fungi . 17 species were isolated on YPG and 7 
on SWA media (Table 2.2) . 
Table 2.2: Summar), of Fungal Isolates. 
Seaweed Medium Endo/ Colony Morphology Code' 
epiphyte 
1.Unidentified YPG Epiphyte Dark orange becoming brown, lAa 
(TSOlO1) sEore-former. 
YPG Epiphyte Grey and woolly lAb 
YPG Epiphyte Grey and woolly lAc 
SWA Epiphyte White and sparse S-lAa 
SWA Epiphyte White with black stalks. S-lAb 
2. Plocamium sp. YPG Endophyte Pink and matted producing a pink 2B 
(TSOlO2) Ei~ent. 
YPG Epiphyte White, dense and aerial with 2Aa 
bubble-like formations. 
3. Gracilaria beckeri YPG Epiphyte Orange/pink with stalks. 3A 
(TSOI03) 
4. Galaxaura YPG Epiphyte White and sparse becoming yellow 4Aa 
diesingiana when mature. Aerial and blanket-
(TSOlO4) like 
YPG Epiphyte Thin and matted. Orange/yellow 4Ac 
with white margin . 
YPG Endophyte Matted. Green with white margins. 4B 
Produces a bright yellow pigment. 
SWA Epiphyte White and transparent becoming S-4A 
dense and aerial on YPG media. 
5. Plocamium YPG Endophyte Yellow and woolly. SB 
corallorhiza 
(TSOI05) 
SWA Endophyte Green and flat becoming white on S-5B 
YPG media. 
6. Gigortina sp. YPG Epiphyte Green with white margins. 6A 
(TSOlO6) 
7. Unidentified YPG Epiphyte Velvety and green 7A 
(TSOl07) 
SWA Epiphyte Light green and matted. S-7A 
YPG Epiphyte White and wooly. Aerial. 7Ad 
S. CanJophyllul1l scalare YPG Epiphyte Velvety dark green with white SA 
(TSOIOS) margin. Matted. 
SWA Endophyte Green and aerial. S-SB 
9. Sargassllln sp. YPG Epiphyte Yellow aerial colonies. Thick. 9Ab 
(TSOlO9) Growth. 
10. Epymeria sp. YPG Epiphyte Dense, grey and matted with white 10Aa 
(TSOI010) nlargin. 
YPG Epiphyte Orange with white margin. lOAc 
Matted. 
SWA Epiphyte White with black stalks but green S-IOA 
on YPG media 
• Code: Number - seaweed number. A - epiphyte; B - endophyte; S - isolated on SW A 
medium. 
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By using both high and low nutrient media, a wider variety and different types of fungi can 
be isolated. Nineteen epiphytic fungi and five endophytic fungi were attained altogether. In 
order to live inside the seaweed, the endophytic fungus would have to penetrate the plant, 
being transferred to the host by spores or through plant vegetative propagules or enter it 
early on in the growing stages (Moore-Landecker, 1982; Saar et aI., 2001). Due to plants 
having a thick cuticle and epidermal wall that resists penetration, we can expect more 
epiphytic than endophytic fungi. However, the small number of endophytic fungi could 
also be due to a long period of surface sterilisation (five minutes) e.g. Hunter-Cevera and 
Belt, 1999, recommend surface sterilization of one minute. Endophytic fungi have been 
shown to be preferred by natural product chemists, not only because of the certainty of their 
origin, but also because their extracts are often biologically active, producing metabolites 
that are toxic to the pathogens and predators of its host (Wicklow, 1988; Gloer, 1999). 
However 80% of the highly metabolically productive fungi isolated in this study were 
epiphytes rather than endophytes. In addition, no fungus was isolated from more than one 
species of seaweed. It is rather interesting that different fungi were isolated from seaweed 
grown in the same area . The exact association between fungi and seaweed however requires 
further investigation. 
2.3.3. Growth Kinetics 
The growth curves (Fig. 2.2) were typical of fungi with a short lag phase when the fungus 
adjusts to the environment. This is followed by a comparatively long log phase of 
exponential growth of the biomass by cell proliferation, culminating in stationary phase 
(Turner, 1971). In some cultures, diauxic growth occurred (Fig. 2.3). This occurs when the 
organism switches from utilising one growth-limiting nutrient to another. 
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Fig. 2.2: Growth Curve of S-1Ab 
23 
Chapter 2: Preliminanj Screening of Secondanj Metabolites from Marine fungi 
Isolate 
1Aa 
lAb 
lAc 
S-lAa 
S-lAb 
2Aa 
3A 
4B 
4Aa 
S-4A 
4Ac 
S-SBa 
SB 
6A 
7A 
S-7A 
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Fig. 2.3: Growth Curve of S-SBa 
Table 2.3: Growth Characteristics of Fungal Isolates on YPG Medium 
Growth Time (Days) 
Lag phase Log phase Stationary phase 
1 10 13 
3 15 20 
2 14 18 
3 13 15 
2.5 10 14 
1.S S 8 
3 13 18 
1.5 6 9 
1.5 6 9 
0.5 6 7 
3 13 15 
6 13 21 
3 15 19.5 
4 16 20 
2 18 22 
4 9 14 
4 10 14 
3 13 18 
4 10 19 
1 4 S.S 
2 13 16.5 
3 14 19 
Glucose 
(f.lglmL) 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Although the colour of the some of the fungi influenced the absorbance, the relative values 
were used as an indication of the initiation of idiophase. Therefore the Somogyi-Nelson 
Assay was used to confirm the advent of stationary phase by checking the complete 
utilisation of reducing sugars (glucose) in the micro titre plate (Table 2.3) and the 2S0mL 
fermentation, assuming this to be the limiting nutrient. Once the reducing sugar has been 
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This infonnation is crucial since the fermentation has to be long enough for secondary 
metabolites to be produced in stationary phase, but for the culture to be harvested before 
toxic metabolites are produced and the secondary metabolites of interest are degraded. The 
complete utilisation of glucose in cultures grown in flasks and the onset of idiophase shown 
by the growth curves of cultures in the microtitre plates show that these results correlate. 
2.3.4. Cultivation of Fungi 
There are many methods of cultivation and several different types of cultivation vessels. 
Types of cultivation methods include solid-state, liquid and bioreactors. However, in both 
industry and academia, small-scale liquid flask cultures are the most frequently used 
(Hilton, 1999; Buchs, 2001). Although these flask cultures suffer from a variety of 
limitations, the greatest one being that they are batch cultures and thus never in a steady-
state, they are the most favourable because they are simple, cheap and small and therefore 
allow many fennentations to be run in parallel (Buchs, 2001). Because this was only a 
primary screening of extracts, flask culture was the most appropriate. 
A B 
Fig. 2.4: A: Mycelial mat resulting from static culture, B: Pellets resulting from shaken 
culture 
Both static and shaken flasks were used. Although the use of static culture was simple, 
inexpensive and allowed for many fermentations to be conducted in parallel, the fungi 
formed an inhomogenous fungal mat (Fig. 2.4). This is because the mat contains mycelia in 
various stages of growth and in a variety of environments. The surface of the mat is 
exposed to more aerobic conditions than that which is below the surface of the medium. 
Thus nutrient uptake is only slowly replaced by diffusion from the lower parts of the 
medium. Static cultures also suffer from oxygen limitation because of the rate of gas 
transfer (Turner, 1971). In contrast, shaken cultures are efficient in the uptake of nutrients, 
resulting in rapid growth and better homogeneity, however, some mycelia may form pellets 
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aggregates (Fig. 2.4B). This results in the centre of these pellets having a lower nutrient 
uptake and oxygen level causing nutrient starvation and idiophase. 
Because fungi produce both extracellular and intracellular secondary metabolites, both the 
broth, containing the extracellular metabolites, and the biomass, containing the intracellular 
metabolites were extracted and analysed for their metabolic creativity. 
2.3.5. Screening of Fungal Extracts 
Table 2.4 shows that cultivation conditions can have drastic effects on the metabolic 
creativity of an organism. For example metabolic creativity is much higher in shake flasks, 
(2Aa mycelium) and (4Ac broth) than static flasks, probably a result of more efficient 
nutrient and oxygen uptake. With most isolates (65%), the broth contained a larger diversity 
of metabolites than the biomass. 
Table 24' Metabolic Creativitx Index of Fungi Grown in Static and Agitated Cultures 
Seaweed Code Isolation Endol Culture Extracted Metabolic 
media e~i~hyte from Creativity 
(1-5)1 
1. Unidentified lAal YPG Epi Static Broth 4 
lAa2 YPG Epi Shaken Broth 4 
lA2B YPG Epi Shaken Mycelia 5 
lAlB YPG Epi Static Mycelia 5 
lAbl YPG Epi Static Broth 5 
lAb2 YPG Epi Shaken Broth 4 
lAblB YPG Epi Static Mycelia 5 
lAb2B YPG Epi Shaken Mycelia 2 
lAc1 YPG Epi Static Broth 2 
lAc2 YPG Epi Shaken Broth 3 
lAc2B YPG Epi Shaken Mycelia 1 
lAc1B YPG Epi Static Mycelia 1 
S-lAal SWA Epi Static Broth 1 
S-lAa2 SWA Epi Shaken Broth 1 
S-lAalB SWA Epi Static Brotil 1 
S-lAa2B SWA Epi Shaken Mycelia 2 
S-lAcl SWA Epi Static Broth 3 
S-lAc2 SWA Epi Shaken Broth 3 
S-lAc1B SWA Epi Static Mycelia 2 
' 1= very low creativity; 2= low creativity; 3= satisfactory; 4= high creativity; 5= very high creativity 
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Seaweed Code Isolation Endol Culture Extracted Metabolic 
media el2il2h.l'te from Creativi!.l' 
(1-5) 
S-lAc2B SWA Epi Shaken Mycelia 1 
2. Plocamiul1l sp. 2B1 YPG Endo Static Broth 5 
2B2 YPG Endo Shaken Broth 5 
2B1B YPG Endo Static Mycelia 1 
2B2B YPG Epi Shaken Mycelia 1 
2Aal YPG Epi Static Broth 5 
2Aa2 YPG Epi Shaken Broth 5 
2Aa2B YPG Epi Shaken Mycelia 4 
2Aa1B YPG Epi Static Mycelia 1 
3. G. beckeri 3A1 YPG Epi Static Broth 3 
3A2 YPG Epi Shaken Broth 1 
3AIB YPG Epi Static MyceHa 1 
3A2B YPG Epi Shaken Mycelia 1 
4. G. diesingiana 4Aa1 YPG Epi Static Broth 5 
4Aa2 YPG Epi Shaken Broth 3 
4A1B YPG Epi Static Mycelia 1 
4A2B YPG Epi Shaken Mycelia 1 
4Ac1 YPG Epi Static Broth 1 
4Ac2 YPG Epi Shaken Broth 5 
4Ac1B YPG Epi Static Mycelia 1 
4Ac2B YPG Epi Shaken Mycelia 1 
4B1 YPG Endo Static Broth 5 
4B2 YPG Endo Shaken Broth 4 
4B1B YPG Endo Static Mycelia 1 
4B26 YPG Endo Shaken Mycelia 3 
S-4A1 SWA Epi Static Broth 1 
S-4A2 SWA Epi Shaken Broth 1 
S-4AIB SWA Epi Static Mycelia 2 
S-4A2B SWA Epi Shaken Mycelia 2 
5. P. corallorhiza 5Bl YPG Endo Static Broth 3 
5B2 YPG Endo Shaken 6roth 3 
561B YPG Endo Static Mycelia 2 
5B2B YPG Endo Shaken Mycelia 1 
S-5Ba2B SWA Endo Shaken Mycelia 1 
S-5Ba1B SWA Endo Static Mycelia 3 
S-5Ba1 SWA Endo Shaken Broth 1 
S-5Ba2 SWA Endo Static Broth 2 
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Seaweed Code Isolation Endo! Culture Extracted Metabolic 
media eEiEhyte from Creativity 
(1-5) 
6. Gigortina sp. 6AI YPG Epi Static Broth 2 
6A2 YPG Epi Shaken Broth 2 
6AIB YPG Epi Static Mycelia 2 
6A2B YPG Epi Shaken Mycelia I 
7. Unidentified S-7AI SWA Epi Static Broth 5 
S-7AZ SWA Epi Shaken Broth 1 
S-7a2B SWA Epi Shaken Mycelia I 
S-7AalB SWA Epi Static Mycelia I 
S-7Ad2B SWA Epi Shaken Mycelia I 
S-7AdZ SWA Epi Shaken Broth 2 
S-7Adl SWA Epi Static Broth 2 
S-7AlB SWA Epi Static Broth 2 
7AI YPG Epi Static Broth 3 
7A2 YPG Epi Shaken Broth 2 
7AlB YPG Epi Shaken Mycelia 3 
7AZB YPG Epi Static Mycelia 3 
8. C. scalare 8Aal YPG Epi Static Broth 3 
8AalB YPG Epi Static Mycelia I 
8A2 YPG Epi Shaken Broth 2 
8A2B YPG Epi Shaken Mycelia I 
S-8BIB YPG Endo Static Mycelia 1 
S-8B2 YPG Endo Shaken Broth 1 
S-8B2B YPG Endo Shaken Mycelia 1 
S-8B1 YPG Endo Static Broth 3 
9. Sargassum sp. 9Ab1 YPG Epi Static Broth 5 
9Ab2 YPG Epi Shaken Broth 2 
9Ab1B YPG Epi Static Mycelia 2 
9Ab2B YPG Epi Shaken Mycelia 3 
10. Epymeria sp. IOAa1 YPG Epi Static Broth 5 
10AaZB YPG Epi Shaken Mycelia 1 
IOAa2 YPG Epi Shaken Broth 4 
10Aa1B YPG Epi Static Mycelia 2 
S-10A1 SWA Epi Static Broth 3 
S-10A2 SWA Epi Shaken Broth I 
S-lOAlB SWA Epi Shaken Mycelia 2 
S-lOAlB SWA Epi Static Mycelia 1 
10Ac1B YPG Epi Static Mycelia 1 
10Ac1 YPG Epi Static Broth 3 
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In recent years, there have been a number of developments on the chemical screening of 
crude extracts including high performance liquid chromatography diode array detection 
(HPLC-DAD) (Frisvad, 1989); HPLC- electro spray ionization (HPLC-ESI) (Smedsgaard and 
Frisvad, 1996; Julian et aI., 1998); liquid chromatography-ultraviolet-mass spectrometry (LC-
UV-MS) (Nielsen and Smedsgaard, 2003) and thermospray-liquid chromatography- mass 
spectrometry (TSP-LC-MS) (Rajakyla et al., 1987). These methods are reliable and provide 
structural information, however they have to be first optimised for separation before 
accurate results can be attained. Natural product chemists also use lH NMR spectroscopy as 
a simple and fast method of screening crude extracts. This method, which is not as sensitive 
as HPLC, allows one to infer the types of compounds contained in an extract making this 
method adequate for primary screening. lH NMR is also sensitive enough to detect 
differences in secondary metabolite production under different growth conditions and can 
be used as a rapid tool for the identification of metabolically productive organisms. An 
experienced natural products chemist can often very quickly dereplicate extracts containing 
only simple metabolites such as fatty acids and sugars while at the same time recognising 
"interesting" structural features of a crude extract. It is also fairly easy to compare the 
effects of different fermentation conditions on the production of metabolites. However, this 
method is quite subjective and minor metabolites may easily be overlooked. It is therefore 
necessary to combine chemical screenings with some form of biological assay. Because this 
method is subjective, a metabolic creativity index was used to rate the extracts. Fig. 2.5 
shows an example of an extract with a low and high metabolic index. 
A typical extract of a culture broth will contain secondary metabolites that have some effect 
on its environment such as antibiotics, mycotoxins, pheromones, insecticides, fungicides and 
herbicides and the intracellular metabolites may contain chemical defense metabolites 
against fungivorous insects and arthropods (Gloer, 1997). However it is only advantageous 
for the organisms to produce these metabolites when required in order to save energy. 
There must be some cue, whether phYSical or chemical, to induce production. Since all 
fermentations consisted of one fungal culture, it was not expected that the broth would 
contain a greater metabolic diversity than the biomass because there was no other organism 
to induce production of eXh'acellular metabolites. This discrepancy could be a result of the 
inhomogenous growth of the fungi, resulting in lysis of cells in death phase, thereby 
releasing its metabolites into the broth. 
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Fig. 2.5: 'H NMR Spectra of a Crude Extract with A: Low Metabolic Creativity and B: High 
Creativity. 
Evidence for this is that several of the intracellular and extracellular spectra are similar. 
Although hundreds of bioactive metabolites have been isolated from the broth of fungal 
media, several new compounds have also been isolated by antagonism i.e, the induction of 
production of bioactive metabolites by introduction of live cells, dead cells or cell extracts of 
another organism (Burgess et a/., 1999). 
Of the 24 fungi, only 10 were observed to exhibit interesting metabolic creativity. These 
were: 
• 2Aa (grown under static conditions; broth extract); 
• 1Aa (grown under agitated and static conditions, broth extract and static conditions for 
the mycelia); 
• 5-7 Aa1 (SW A isolation medium, grown under agitated conditions; broth extract); 
• 4Aa (grown under static conditions, broth extract); 
• 2Ba (grown under static conditions, broth extract); 
• 10Aa (grown under static conditions, broth extract); 
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• lAb (grown under static and Shaken conditions, broth extract and static conditions, 
mycelium); 
• 4Ac (grown under Shaken conditions, broth extract); 
• 4B (grown under Shaken and static conditions, broth extract); 
• 9Ab (grown under static conditions, broth extract) 
2.3.6. Bioactivity 
2.3.6.1. Cytotoxicity Assays 
The cytotoxicity assays show that most of the extracts tested were cytotoxic to brine shrimp 
at their highest concentration (570~g/ mL) (Table 2.5). Most extracts acted in a dose-
dependant manner i.e. as the concentration decreased, the percentage mortality decreased. 
Due to small quantities of extracts from some isolates, only a few extracts could be tested, 
therefore no comparison can be made regarding the culture techniques employed and 
bioactivities of the metabolites produced. 
Table 25' Brine Shrimr> Mortality ( 'J( ) .. 0 
Isolate Culture Extract Metabolic Average Mortality {'v"j 
Creativity 
Concentration (fJ&,mL) 
570 285 142 71 
5-5BalB Static Mvcelia 2 100 100 95 100 
4Bl Static Broth 4 100 100 100 96 
4B2 Shaken Broth 4 100 100 88 72 
10Aa Static Mvcelia 5 100 100 88 70 
2AalB Static Mycelia 1 0 0 0 0 
2Ba2B Shaken Mvcelia 4 100 83 71 50 
2Ba2 Shake Broth 5 100 100 100 100 
5-7Ad2 Static Broth 5 100 90 85 80 
lAalB Static MYcelia 5 100 100 80 60 
lAa2B Shaken MYcelia 5 100 50 0 0 
3A1 Static Broth 3 100 90 33 20 
5-10Aal Static Broth 3 100 100 100 100 
S-5BalB Static Mvcelia 3 100 100 100 100 
2-Aal Static Broth 5 100 100 100 100 
10AalB Static Mycelia 2 100 100 100 100 
4AalB Static Mycelia 1 100 100 100 100 
S-5BIB Static Mvcelia 3 100 41 10 10 
5-8Bl Shaken Broth 1 100 100 100 100 
3AIB Static Mycelia 1 0 0 0 0 
S-4A Shaken Broth 1 0 0 0 0 
10Ac2B Static Mycelia 1 100 87 70 66 
5-1A2B Shaken MYcelia 2 10 6 8 5 
5B1 Static Broth 3 0 0 0 0 
8AalB Static Mycelia 4 100 100 100 84 
lAa1 Static Broth 5 100 100 100 100 
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2.3.6.2. Anticancer Assay 
The crude extracts which showed some activity against cancer cell lines WHeOl 
(oesophageal cancer line) and MEISO (cervical cancer line), were: 
• S-7AD2 
• S-SBI 
• 4Bl 
• 8AalB 
• lAalB 
• lOAc2B 
• 4B2 
The extracts that were active against the cancer cell lines were also cytotoxic to brine-shrimp. 
Therefore a good correlation exists between our assays. 
2.3.6.3. Antibiotic Assays 
No antibiotic activity was observed for any of the samples tested against methicillin resistant 
microorganisms. However, no assays against non-resistant microorganisms were 
investigated. 
2.4. Summary and Recommendations 
Seaweeds are a good source of fungi, with more epiphytes being isolated than endophytes. 
Most of the crude broth extracts exhibited a higher metabolic creativity than the biomass 
extracts, while most isolates produced higher creativity indices when grown under shaken 
than static growth conditions. Some of these extracts were active against brine-shrimp and 
cancer cell lines, while none showed antibiotic activity against methicillin resistant bacterial 
strains. 
Although SW A and YPG isolation media were effective in isolating a number of different 
fungi, a variety of media should be used to assess whether other fungi can be isolated. 
Although flask cultures have many disadvantages, their simplicity, cost-effectiveness and 
the ability of running simultaneous fermentations, makes their use suitable for primary 
screening of fungal isolates. 
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The production of spores is a good indication of stationary phase, however where diauxic 
growth occurs, or when fungi are non-sporulating, other methods of analyses are required. 
While the use of optical density may not be suitable to coloured fungi, a conjunction of these 
methods is adequate to acquire information on the growth phases of the cultures. 
Extraction of metabolites using solvents is a time-consuming and costly process, therefore 
alternate methods are recommended such as extraction with reusable resins or the use of 
high molecular exclusion filters for extraction. 
It is also important to note that although 'H spectra of extracts may not be "interesting", 
these extracts may still possess potent biological activity. It is thus essential that metabolic 
screening be done in conjunction with bioassays. These methods of screening are quick and 
inexpensive, however the analyses of spectral data are subjective. If interpreted correctly, 
this method can be used effectively to screen fungi .. 
2.5. Conclusion 
Based on the metabolic creativity screening and the bioactivity screening of the crude 
extracts, isolate lAa (RUC010l) was chosen for further study. 
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Chapter 3: Jdentification ofRUC0101 
3.1. Introduction 
An important element of natural product chemistry is dereplication. Dereplication has been 
defined by Kohlmeyer and Kohlmeyer (1979) as the elimination of replicates or repeats of 
material already isolated and known in the literature. An initial step in dereplication is the 
identification of the source organism. The taxonomy of fungi has traditionally been based 
on morphology, but morphology is only a part of the expression of differentiation in living 
organisms (Frisvad, 1989). 
Other methods for the identification of microorganisms include analyses of: (1) secondary 
metabolite profiles using liquid chromatography- nuclear magnetic resonance (LC-NMR) 
(Bobzin et aI., 2000); high-performance liquid chromatography-electrospray ionization 
(HPLC-ESI) (5medsgaard and Frisvad, 1996; Julian et al., 1998); HPLC with alkylphenone 
retention indices (Frisvad, 1987); gas chromatography-mass spech'ometry (GC-MS) (Frisvad 
et al., 1989); thin layer chromatography (TLC) (Frisvad et aI., 1989) and liquid 
chromatography-ultraviolet-mass spectrometry (LC-UV-M5) (Nielson and 5medsgaard, 
2003), (2) intracellular and extracellular components such as sterols (Van Eijk and Roeymans 
1982); long chain fatty acids (Lee et aI., 1976); polyols (Pfyffer and Rast, 1980); cell wall 
carbohydrates (Leal et aI., 1984) or GC of whole cells (Kullik and Vincent, 1987). Fatty acid 
methyl ester (FAME) using GC is also a widely used method that has been successfully 
applied to the identification of fungal species. However, the concerns with using 
chemotaxonomy are that (1) compounds are not unique to species e.g. aflatoxins are 
produced by many species of Aspergillus and (2) isolates in a given species may fail to 
produce one or two of the most diagnostic secondary metabolites (Frisvad, 1989) due to 
differences in cultivation or strain degeneration. Thus the use of secondary metabolites or 
intracellular components as taxonomic markers may render results that are questionable. 
Since morphology and the production of metabolites are a result of the genetic information 
of an organism, a direct approach is to identify the organism using their DNA. Phylogenetic 
studies in eukaryotes utilise the ribosomal DNA (rONA) (285, 5.85 and 185 ribosomal sub-
units) (Fig. 3.1). There are two internal transcribed spacers, the IT51 and IT52, which 
separate the 185, 5.85 and 285 genes. 
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185 
ITSl r 
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IT51 I 5.85 
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IT5 2, 
ITS3r 
--
IT52 
Fig. 3.1: rDNA of Eukaryotes. 
<-
ITS 4, 
285 
ET5: external transcribed region; IT5: internal transcribed spacer. 
Arrows indicate direction of respective forward and reverse primers. 
Choosing an appropriate region for analysis is of extreme importance. Bruns et aI., (1991) 
identified several factors to consider when selecting a region for sequence analysis: 
1) The region should be evolving at an appropriate rate for comparison of interest. Regions 
that are too conserved will provide too few changes, and regions that are too variable 
will contain too many inconsistent characters due to multiple substitutions at single 
positions. 
2) The region should be present ideally as a single copy or should at least evolve like a 
single copy region e.g. rDNA, mitochondrial DNA (mtDNA). 
3) The region should have the same function in all taxa because evolution of a new function 
changes selective pressures and therefore the rate of sequence change. 
4) The effect of base composition and codon bias should be examined because both factors 
can distort estimates of variance. 
The 185, 235 and 5.85 genes evolve at very different rates, thus they are more likely to yield 
informative data for systematics. Furthermore, the islands of highly conserved sequences 
are useful for constructing universal primers that can be used for sequencing (Hillis and 
Dixon, 1991). The most studied rRNA in eukaryotes is the 185 because it is amongst the 
slowest evolving sequences. Thus it is useful for examining ancient evolutionary events 
through the Precambrian period. The large subunit, 285 is larger and shows more variation 
in rates of evolution. It has been used to study events through the Paleozoic and Mesozoic 
period. The 5.85 rRNA is however too short and its usefulness for phylogenetics is therefore 
limited (Hillis and Dixon, 1991). Until recently, the spacer regions of the rONA were not 
frequently used, however it is now known that these regions can infer phylogeny among 
closely related taxa (which have diverged within the last 50 million years). These regions 
can also identify up to strain or species level (Hillis and Dixon, 1991) and have now become 
popular regions for identification of isolates. Due to this, many sequences have been 
submitted to the GenBank (an electronic database), and are readily available for sequence 
comparison. 
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With the advent of direct sequencing of polymerase chain reaction (PCR) products, the cost 
and time of sequencing has decreased significantly. The circumvention of cloning (bacterial 
transformation, plasmid preparation, creation of libraries and fragment purification) aids the 
number of isolates which can be studied simultaneously. 
In this chapter the identification of RUC0101 by direct sequencing of the ITS1 and 2 regions 
is described. 
3.2. Materials and Methods 
3.2.1. DNA Analyses 
3.2.1.1. Cultivation and Isolation of DNA 
DNA was extracted from 0.5cm' of mycelia maintained on YPG plates using QIAgen 
DNeasyTM Tissue Kit (Southern Cross Biotechnology) following the modified protocol for 
yeast cells. The mycelia were digested by lyticase (yeast lysis enzyme) 5500Uj g, (ICN 
Biomedicals, Inc) and subsequently suspended in 600J.!L sorbital buffer (1M sorbital; 100mM 
EDT A; 14mM 13-Mercaptoethanol), followed by centrifugation for 10 minutes at 500 x g 
using an Eppendorf Centrifuge 5810R. The pellet was resuspended in a further 600J.!L of 
sorbital buffer. 200 units (100J.!L of 2000U j mL stock) of lyticase were added to the mycelia 
and the samples were incubated at 30°C for 30 minutes. The spheroplasts were pelleted by 
centrifugation for 10 minutes at 300 x g and the pellet resuspended in 180llL ATL buffer (60-
00-4 edetic acid: 2.5-10%; 151-21-3 SDS: 2.5-10%). The protocol used for the isolation of 
genomic DNA was carried out as described in the QIAgen DNeasyTM Tissue Kit Handbook 
(1999). 
The purity and integrity of the extracted genomic DNA was evaluated using 0.8% agarose 
gel (molecular grade DI-LE, WhiteSci) containing ethidium bromide (EtBr) (O.5J.!gjmL) in 
O.5X TBE buffer (Appendix A) after electrophoresis at 100V. The DNA was visualized on a 
UV transilluminator. 
The DNA was quantified using the Pharmacia GeneQuant with a 1:100 dilution of the 
extracted DNA. 
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3.2.1.2. Amplification of ITS1 and ITS2 regions 
Primers for the ITS1 region where chosen according to Brookman et ai., (2000) and obtained 
from Takara (Biolnc, Japan). ITS2 region primers were chosen according to White et aI., 
(1990), and were purchased from Inquaba Biotech (Pretoria, South Africa). Using these 
primers, the sizes of the PCR products were expected to be 300 - 400 bp's. The primers were 
reconstituted in triple distilled waster (dddH20) to make a stock solution of 100f.lM. 
Primer Sequence 
ITS1 forward 5' TGTACACACCGCCCGTC 3' 
ITS1 reverse 5' CTGCGTTCTTCA TCGA T 3' 
ITS2 forward 5' GCATCGATGAAGAACGCAGC 3' 
ITS2 reverse 5' TCCTCCGCTTATTGATATATGC 3' 
Melting Temperature (Tml 
58°C 
50°C 
62°C 
62°C 
A 100f.lL reaction was prepared according to the Promega PCR Master Mix instruction 
manual (Promega, USA). The Master Mix consisted of 50U/mL of Taq Polymerase (pH=8.5), 
400f.lM dATP, 400f.lM dGTP, 400~lM dCTP, 400f.lM dTTP and 3mM MgCh 
Table 3.1: Reagents and Final Concentrations used in PCR Reactions for the ITS1 and ITS2 
Regions. 
Reagent Amount Final Concentration 
Mas ter Mix (2X) 5Of.lL 1X 
Template DNA 3f.lL < 250ng 
ITS1 primer (10f.lM) 5f.lL 0.5f.(M 
ITS2 primer (10f.lM) 5f.lL O.5f.lM 
Water 37f.lL 
Total 1OOf.lL 
The negative control was prepared as above without the template DNA. 
The PCR was performed with the PCR Sprint Hybaid using the following cycle parameters: 
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ITS1 region 
• Initial denaturation temperature: 95°C for 2 minutes 
30 cycles of: 
• Denaturation: 95°C for 1 minute 
• Annealing: 45°C for 1 minute 
• Extension: 72°C for 1 minute 
• Final extension: 72°C for 5 minutes 
ITS2 region 
• Initial denaturation temperature: 95°C for 2 minutes 
30 cycles of: 
• Denaturation: 95°C for 1 minute 
• Annealing: 57°C for 1 minute 
• Extension: 72°C for 1 minute 
• Final extension: 72°C for 5 minutes 
3.2.1.3. Electrophoresis 
Amplified products were visualised in 1 % agarose gels (Appendix A) after electrophoresis at 
100V. DNA molecular marker XIV (250J.1g/mL in 10mM Tris-HCI, 1mM EDTA, pH~8) 
(Roche) was used for the ITS1 region and A DNA Pst molecular marker (10ngIJ.IL) for the 
ITS2 region. The DNA was viewed with a UV transilluminator and photographed using a 
Kodak digital camera. The data was captured using Kodak Digital Science ID v.2 software. 
3.2.1.4. DNA Extraction from Gel 
The products were excised from the agarose gel and the amplified DNA extracted using the 
QIAquick Gel Extraction Kit according to the manufacturer's instructions (QIAquick Spin 
Handbook, 2001). The DNA was quantified using the Pharmacia GeneQuant at 260nm. 
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3.2.1.5. Cycle Sequencing 
Table 3 2' Reagents for Cycle Sequencing of Both the Forward and Reverse Strands ..
Reagent Amount 
Template DNA 3-10ng 
Primer 1/ Primer 2 3.2pmol 
Big Dye* 4flL 
Dilution Buffer 2flL 
Water made up to 20flL 
* Big Dye Termmator v 3.1. Cycle Sequencmg KIt. 
The GeneAmp PCR system 9700 thermocycler was used with the following parameters: 
ITS1 
• Initial denaturation: 96°C for Is 
25 cycles of: 
• Denaturation: 96°C for lOs 
• Annealing: 45°C for 5s 
• Extension: 60°C for 4min 
• Initial denaturation: 96°C for Is 
25 cycles of: 
• Denaturation: 96°C for lOs 
• Annealing: 50°C for 5s 
• Extension: 60°C for 4min 
3.2.1.6. DNA Purification 
The DNA was purified for sequencing using the DNA Clean & Concentrator KitTM. lOOflL of 
DNA binding buffer was added to each sample. The samples were then loaded onto a 
Zymo-Spin column placed in 2 ml collection tubes, centrifuged at 10 000 x g for 10 seconds 
and the flow-through discarded. 200flL of wash buffer was added to each column and the 
samples centrifuged for 10 seconds at maximum speed. The flow-through was discarded 
and another 200flL was applied to the column. The samples were centrifuged for 30 seconds 
at 10 000 x g and the flow-through discarded. To elute the DNA, 8flL of dddH20 was 
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applied directly to the column matrix. The Zymo-Spin column was placed in a sterile 
eppendorf and centrifuged for 10 seconds at 10 000 x g. The DNA was dried at 37°C 
3.2.1.7. Electrophoresis 
Samples were sequenced using the ABI 3100 Genetic Analyzer (Applied Biosystems Div., 
Perkin-Elmer Biosystems, U.s.A.). 
3.2.1.8. Analyses of Sequence Results 
Chromatograms were generated by the ABI PRISM Genetic Analyser Data Collection System 
1.0.1 (Applied Biosystems). The resulting sequences were viewed using Chromas v. 2.23 
and the sequence output corrected manually. The data were converted into a text file and 
aligned using BLAST pairwise alignment. The forward sequence was divided into the 
respective regions i.e. 18S, ITSl, and 5.8S, and the ITS1 sequence was compared to those in 
the GenBank using BLAST (Basic Local Alignment Search Tool) (Altschul et al., 1997) 
(http://www.ncbi.nlm.nih.gov/cgi-bin/BLAST).Using these data, BLAST generated a list 
of the most closely related fungi. The sequences of the fungi homologous to the ITS1 region 
were aligned using ClustalX v.1.81 alignment algorithm (Thompson et ai., 1997) with the 
default settings. The truncated sequences and non-homologous regions from the sequences 
were deleted as described by Hall (2001) . The length of the ITS1 sequence used for sequence 
alignment and the construction of the phylogenetic tree was 147 bp's. A non-rooted 
Neighbour Joining phylogenetic tree (Fig. 3.4) was constructed using ClustalX with the 
default parameters for bootstrapping. Treeview v.1.61 was used to view the phylogenetic 
tree. 
3.2.2. Microscopic Analyses 
Seven-day-old pieces of mycelia (5mm3) maintained on YPG agar were treated in cold-
buffered fixative (2.5% glutaraldehyde in O.lM phosphate buffer) overnight. The buffer was 
decanted and replaced twice with cold phosphate buffer for 15 minutes. This was replaced 
with a series of ethanol concentrations from 30-100% for 15 minutes each. Thereafter the 
100% ethanol was replaced with 25%, 50 %, 75% and finally 100% amyl acetate: EtOH for 20 
minutes each. The specimens were then transferred to the critical point drying apparatus 
and dried for 2 hours. Thereafter the samples were coated with gold as described by Cross 
(2001, unpublished manual). A JEOL JSM 840 SEM was used to magnify the specimens. 
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Fig. 3.2: PCR Products of the ITS1 and ITS2 Regions Visualised on a 1 % Agarose Gel after 
Electrophoresis at 100V. 
A: ITS1. Lane 1-4 = PCR products. Lane 5 = negative control. Lane 6 = DNA molecular 
weight marker XIV. B: ITS2. Lane 1 = negative control. Lane 2 = PCR product. Lane 3 = A 
DNA Pst marker. 
Table 3.3: Most Closely Related Species using the ITS1 Region 
Species Similarity (%) Score E-value Base pairs 
Eurotium rubrum strain SRRC 2172 100 291 2e-76 147/147 
E. ntbntm 100 287 2e-75 145/ 145 
E. niveoglaucum NRRL 137 99 283 4e-74 146/147 
Newtonia buclumanii wood isolate S35 99 283 4e-74 146/147 
E. repens strain A TCC 66457 99 283 4e-74 146/147 
Cordyceps sinensis isola te W1023 99 283 4e-74 146/147 
E. herbariorum strain NRRL 116 98 280 6e-73 145/147 
E. repens isola te W8 99 280 6e-73 146/147 
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Table 3 4· Most Closelx Related S)2ecies using the ITS2 Region 
Species Similarity (%) Score E-value Base pairs 
E. niveoglaucum NRRL 137 100 331 2e-88 167/167 
Newtonia buchananii wood isolate S35 100 331 2e-88 167/167 
E. mbrum strain SRRC 2172 100 331 2e-88 167/167 
E. repens A TCC 66457 100 331 2e-88 167/167 
E. herbariorum strain NRRL 116 100 331 2e-88 167/167 
Cordyceps sinensis 100 331 2e-88 167/167 
E. rubmm 100 331 2e-88 167/167 
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E . amstelodami wb 2 
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E. chevalieri NRRL 78 
E.repens 
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Newtonia buchananii isolate 
E . herbariorum NRRL 116 
E.repens strain ATCC 66457 
Thuidium cymbifolium 
E.rubrum 
E.rubrum SRRC 2172 
E.amstelodami wb 212 
E.amstelodami wb 345 
E.amstelodami wb 338 
E.rubrum wb 269 
E.rubrum wb 190 
E.amstelodami NRRL 90 
E . cevalieri NRRL 78 
E.repens 
E.niveoglaucum NRRL 137 
Newtonia buchananii isolate 
E.herbariorum NRRL 116 
E.repens ATCC 66457 
Thuidium cymbifolium 
10 20 30 40 50 
......... I ··.··· .. · I ......... I ........ . I ... .. .... I 
--TACCGAGTGCGGGCCCTCTGGGTCCAi'£C TCCCATCCGTGTCTATCTG 
ATTACCGAGTGCGGGCCCTC TGGGTCC.~CCTCCCATCCGTGTC TATCTG 
" TTACCGAGTGCGGGCCCTCTGGGTCCAACC TCCCATCCGTGTCTATCTG 
ATTACCGAGTGCGGGCCC TCTGGGTCCAJ'..CC TCCCATCCGTGTCT.'ITCT': 
ATTACCGAGTGCGGGCCC TCTGGGTCCAACC TCCCATCCGTGTCTATCTG 
ATTACCGAGTGCGGGCCCTC TGGGTCCA-~CC TCCCATCCGTGTCTATC TG 
ATTACCG.;;GTGCGGGCCC TCTGGG TCCAACC TCCCATCCGTGTCTi'<.TCTG 
.'ITT.l\CCGAGTGCGGGCCC TCTGGGTCCilACCTCCCATCCGTGTCTATCTG 
ATTACCGAGTGCGGGCCCTCTGGGTCCAi'£CTCCCATCCGTGTCTATCTG 
--TACCGAGTGCGGGCCCTCTGGGTCCAACCTCCCATCCGTGTCTATCTG 
ATTACCGAGTGCGGGCCCTCTGGGTCCAACC TCCCATCCGTGTCTATCTG 
ATTACCGAGTGCGGGCCCTCTGGGTCCAACCTCCCATCCGTGTCTATCTG 
ATTACCGAGTGYGGGCCCTCTGGGTCCAACC TCCCATCCGTGTCTATCTG 
- --ATr;.CCGAGTGCGGGCCCTCTGGGTCCA~.CC TCCCATCCGTGTC TATC TG 
! .TTACCGAGTGCGGGCCCTCTAAATCCAA.CC TCCCATCCGTGTCTATCTG 
60 70 80 90 100 
..... . . .. I . .... .. .. I · · ....... I . .. ...... I .. ... .... I 
TACCCTGTTGCTTCGGCGTGGCTACG3CCCGCCGA" GACTAACATTTGAA 
TACCCT, TTGCTT CGGCGTGGCTACGGCCCGCCGAAGACTAACATTTGAA 
- - -TACCCTGTTGCTTCGGCGTGGCCACGGCCCGCCGGAGAC~~CATTTGAA 
TACCCTGTTGCTTCGGCGTGGCCACGGCCCGCCGGAG-,C TAACATTTG.~ 
TACCCTGTTGCTTCGGCGTGGCCACGGCCC GCCGGAGACTAACATTTGAA 
TACCCTGTTGCTTCGGCGTGGCCACGGCCCGCCGGAGACTAACATTTG;\A 
TACCCTGTTGCTTCGGCGTGGCCACGGCCCGCCGGAGAC~l\hCATTTGAA 
- - -
TACCCTGTTGCTTCGGCGTGGCCACGGCCCGCCGGAGACTAACATTTGAA 
- - -TACCCTGTTGCTTCGGCGTGGCCACGGCCCGCCGGAGACTAACATTTGAA 
- - -
T."CCCTGTTGCTTCGGCGTGGCC.'ICGGCCC ::CCG.~GACTAACATTTGAA 
- - -
TACCC TGTTGCTTCGGCGTGGCCACGGCCCGCCGAAGACTAACATTTGAA 
TACCCTGTTGCTTCGGCGTGGCCACGGCCCGCCGAAGACTAACATTTGAA 
- - -TACCC TGTTGCTTCGGCGTGGCCACGGCCCGCCGAAGACTAACATTTGAA 
- - -TACCCTGTTGCTTCGGCGTGGCCACGGCCCGCCGAAGACTAACATTTGAA 
- - -TACCCTGTTGATTCGGCGTGGT-ACGGCCCGCCG~GAATAACATTT~~ 
110 120 130 140 
......... I ........ . I ......... I .. .. .... . I .. .. .. . . 
CACTGTCTGA.l\GTTTGCAGTCTGAGTTTTT GTTAAACAATAATT.l\A 
CACTGTCTGAAGTTTGCAGTCT~AGTTTTTAGTTAAACA.tI.TAATTAA 
- - -CGCTGTCTGAAGTTTGCAGTCTGAGTTTTTAGTTAAACAATCGTTA-
C~C TGTCTGAAGTTTGCAGTCTGAGTTTTTAGTTAAACAATCGTT~ 
CGCTGTCTGAAGTTTGCAGTCTGAGTTTTTAGTTAAACAATCGTTAA 
CGCTGTCTGAAGTTTGCAGTCTGAGTTTTTAGTTAAACAATCGTT 
CGCTGTCTG'\,,\GTTTGC1,GTCTGAGTTTTTAGTTi ·.AACl;ATCGTTAA 
- - -
C~C TGTC TGAAGTTTGCAGTCTGAGTTTTTAGTTAAA~~TCGTTA.l\ 
CGCTGTCTGAP GTTTGCAGTCTGAGTTTTTAGTTAAACAATCGTTAA 
- - -CAC TGTC T~l\jlETTTGCAGTC TGAGTTTTTAGTT.~CAATAATTAA 
C~CTGTC TGAI,GTTTGCAGTC TGAGTTTTTAGTTAAACAATA>'TT.~ 
CACTGTCTGAAGTTTGCAGTCTGAGTTTTTAGTTAAACA.l\TAATTAA 
CACTGTC TG~AGTTTGCAGTC TGAr,TTTTTAGTTAAACAP.TAATTA,' 
CAC TGTC TGAAGTTTGCAGTCTGAGTTTTTAGTTAAACAATAATTr~ 
- --C' CTGTCTGAAGTTTGCAGTCTGAGTTTTTAGTTAAAC.l\ATA,'TT 
- -
Fig. 3.3: Multi-alignment of Closely Related Species using the iTSl Region. 
Generated by ClustalX using the default parameters for bootstrapping. 
Underlined bases indicate low-scoring regions. 
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Fig. 3.4: Phylogenetic Tree constructed from the ITSI region of RUCOI0l. 
Generated from closely related species identified from BLAST search. 
Taxonomy: Eukaryota; Fungi; Ascomycota; Pezizomycotina; Eurotiomycetes; Eurotiales; 
Trichocomaceae; Eurotium 
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3.3.2. Microscopic Analyses 
A B 
Fig. 3.5: SEM of RUC0101. 
A: helical antheridia and ascogonia resulting in the formation of the c1eistothecium and 
ascocarp (yellow) during sexual reproduction (xllOO). B: single somatic hyphae terminating 
in conidiaphores bearing sterigmata (x800). 
Rue 0101 
Fig. 3.6: RUC0101 Maintained on YPG Basal Medium. 
3.4. Discussion 
The isolation of genomic DNA and the resultant amplification of the ITS1 and ITS2 regions 
using PCR were successfully accomplished without the need for further optimisation. PCR 
of the ITS1 and ITS2 (Fig. 3.2) region yielded one fragment each between 300 and 400bp's 
and this was confirmed by sequencing. The pairwise alignment of the forward and reverse 
strands for both regions revealed no secondary structures and was subsequently used for 
phylogenetic studies. The primers chosen also allowed the short 5.85 region (108bps) to be 
attained because the ITS1 primers permit the PCR of the 5' end of this region (flanks the 3' 
end of the ITS1 region) and the ITS2 primers PCR the 3' end (flanks the 5' end of the ITS2 
region) (Fig. 3.1). 
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The results from the ITS2 (Table 3.4) and 5.8S regions of RUCOI01 show 100% homology 
with many species of the genus Eurotium while the ITS1 region of RUCOl01 shows 100% 
homology with only Eurotium rubrul1l strain SRRC 2172 (Haugland et al., 2003) (Table 3.3). 
Al though, phylogenetic studies based on the 5.8S region are already known to produce 
ambiguous results, in this case, the ITS2 region was also too conserved and therefore not 
suitable for species identification. For the ITS1 region, the high score (291 bits) and a low e-
value (2e-76) suggest that these results are of high quality. 
Fig. 3.5 clearly shows typical structures of fruiting bodies of the EU1'Otium sp. (Ainsworth et 
aI., 1973), with both the asexual and sexual states being produced (Florian and Manning, 
2000). The morphology of RUC0101 is consistent with Raper and Fenell's description of the 
Aspergillus glaucus group as having aerial hyphae encrusted with yellow, orange or red 
granules. In addition, maximal development and production of the cleistothecia (yellow-
orange to brown-red), with limited growth of conidia (green) occurs when grown in a 
medium high concentrations of sugar and limited nitrogen (Raper and Fenell, 1965) such as 
YPG basal medium. 
Although the DNA sequencing results were of high quality and consistent with that of the 
microscopic analyses, a full taxonomic analyses which includes physiological testing and 
possibly chemotaxonomy would be required to be certain that RUC0101 is identical to 
Eurotium 1'llb1'llm strain SRRC 2172. 
The Aspergillus/ Eurotium genus is widely distributed from the Poles to the Tropics. They are 
capable of utilising a variety of substrates for food because of the large number of enzymes 
they produce (Alexopoulos, 1962). In fact, they are so common that in a recent PhD thesis, a 
low nutrient isolation medium was specifically used to decrease the chance of isolating these 
ubiquitous fungi (Holler, 1999). 
E. rub1'llm otherwise known as Aspergillus ruber (anamorph) belongs to the Aspergillus glaucus 
group. It is a halotolerant fungus and has been isolated from the Dead Sea (Kis-Papo et aI., 
2001; Kis-Papo et al., 2003) and the marine environment (Christophersen et aI., 1999). 
However, E. rubrum is also a xerophillic fungus and has been commonly isolated as a food 
spoilage microorganism (Ismail, 2000; Peintner et aI., 2000; Weidenb!rner, 2000). The 
possibility that this isolate is a contaminant is unlikely because stringent collection and 
isolation procedures were followed. In addition, none of the other plates or the controls 
contained this fungus . According to the definition by Kohlmeyer and Kohlmeyer, (1979), 
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RUC0101 is a marine fungus because it is able to grow and sporulate in the marine 
environment. 
From the 1900's to the 1970's, the Aspergillus giauclls group was of great interest to 
researchers . The initial interest was due to the ubiquitous nature of the fungus which arose 
from its interesting metabolism. This group has been known to produce a number of 
anthraquinones, indoles and prenylated hydroquinones (Raistrick et ai., 1937; Cruickshank et 
aI., 1938; Barbetta et ai., 1969; Allen, 1972; Cardillo et ai., 1974; Gatti, 1976; Gatti, 1978, Gatti 
and Fuganti, 1979). The study of this group was pursued because of the types of compounds 
produced and the biological activity associated with them. The anthraquinones in particular 
gained interest due to their anti tumour and antibiotics activities (Podojil et aI., 1978; Anke et 
ai., 1980a; Anke et aI., 1980b; Arai et aI., 1989; Manojlovic et aI., 2000; Yen et al., 2003). 
3.5. Conclusion 
Using DNA analyses of the ITS1 region, RUC0101 has been identified as a close relative of 
Eurotillm rubrum. Although E. rubrum has been isolated from the marine environment, no 
investigations have been undertaken to determine the adaptation of these isolates to the 
marine environment. Thus one of the objectives of this study is to determine if any new 
metabolites are produced by RUC0101. Furthermore because this group has been well 
studied, the results from our investigation can be used to evaluate the methods employed. 
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4.1. Introduction 
4.1 .1. Optimisation 
It is well recognised that small changes in growth media and fermentation conditions can 
cause the expression of different secondary metabolites in microorganisms (Bu'Lock, 1975). 
By varying the fermentation conditions, the optimum parameters for the production of (1) a 
single high-value metabolite or (2) a range of metabolites (metabolic creativity) can be 
determined. With the large number of known metabolites being isolated from 
microorganisms it is essential to optimise the fermentation conditions in order to increase the 
chances of finding new metabolites. However, it is not feasible for an academic research 
group, interested in discovering new chemical entities, to optimise culture conditions for 
each new microorganism that is isolated. In this study we wished to evaluate whether our 
standard fermentation protocol allowed us access to all the major metabolites of our marine 
isolate of E. rubru11l. A commonly encountered strategy for optimisation studies is the "one-
factor-at-a-time" method. This method involves optimising one factor first (e.g. carbon 
source), then using this optimised carbon source to optimise the next factor (e.g. nitrogen 
source) etc. The two main disadvantages of this method are: (1) it is laborious and time-
consuming, and (2) it does not take into consideration interactions between components of 
the media. 
4.1.2. Composition of Fermentation Media 
Fungi require carbon, nitrogen, phosphorus, sulphur, minerals, vitamins and other growth 
factors. They may also require specific nutrients that they are unable to synthesise, such as 
amino acids and vitamins (Greasham and Herber, 1997). They are sensitive to hydrogen ion 
concentrations (pH), temperature, and oxygen/carbon dioxide in the environment. The 
major challenge is to provide the fungus with conditions that allow for the expression of 
secondary metabolites and the accumulation of unusual products (Pearce, 1997). Nutrients 
have to be supplied to first establish growth and then to maximise secondary product 
formation. In addition, the cost, consistency in composition and availability also need to be 
taken into consideration (Dahod, 1999) . 
Required nutrients may be supplied via either chemically defined or complex media. 
Chemically defined media consist of both organic and inorganic ingredients that are 
chemically defined (e.g. glucose; glycerol), while complex media consists of one or more 
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nutritional components that cannot be easily defined (e.g. soybean flour; corn steep liquor; 
peptone). When a complex medium contains several chemically defined nutrients and only 
one complex component, it may be referred to as a semi-defined medium. 
(1) Chemically defined media: At small-scale production, these types of media are routinely 
used to develop a fundamental understanding of the nutritional requirements of the isolate, 
which is impossible with complex media. Traditionally chemically defined media have been 
unattractive at commercial scales for the production of secondary metabolites because of 
their relatively high costs and support of low productivities (Dahod, 1999). However they 
are slowly gaining popularity with the production of recombinant proteins at levels equal to 
or greater than those achieved with complex media. Furthermore they have the inherent 
characteristic of supporting consistent fermentation performance. Fermentations developed 
with chemically defined media often lead to rapid scale-up and are less sensitive to large-
scale sterilisation (Dahod, 1999). 
(2) Complex media: Most industrial fermentations are complex formulations. These 
ingredients are cost-effective and support faster and increased cell mass (Dahod, 1999), 
however as mentioned previously, consistency is a problem because these types of media are 
by-products and waste materials from the agricultural and food industries or extracts of 
biological materials (Greasham and Herber, 1997). 
Microorganisms utilise carbon compounds for the production of cell mass and secondary 
metabolites, as well as for an energy source. The concentration of the C-source is also an 
important factor for growth and production of metabolites. For fungi, carbon and nitrogen 
constitute 48 and 6% of the dry weight, respectively (Greasham and Herber, 1997). If the 
concentration is too high, the microorganism may experience dehydration. Glucose, usually 
an excellent carbon source for growth, interferes with the biosynthesis of many secondary 
metabolites (Demain et aI., 1992). Also required is nitrogen to support the biosynthesis of 
nitrogenous metabolites, both primary (purines, pyrimidines and amino acids) and 
secondary. Both organic and inorganic nitrogen sources have been used in the culture media 
for other members of the Aspergillus glaucus group. Gould and Raistrick (1934) reported that 
with A. novus (a closely related fungus to E. rubrum), di-ammonium tartrate produced higher 
yields of metabolite than with sodium nitrate as a nitrogen source and A. umbrosus, another 
relative, grew better on ammonium than nitrate nitrogen (Carbone and Johnson, 1964). 
Although glucose affects biosynthesis, it is still a common approach when develO\QPi;f: :e~~~ \ 
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to add glucose because it is a rapidly utilisable sugar, in addition to a slowly utilisable sugar 
such as mannitol together with a nitrogen source and minerals. This frequently results in 
rapid growth of the fungus due to the glucose and then a slower growing phase favouring 
secondary metabolism. 
Ammonium and phosphate levels also control secondary metabolism and secondary 
metabolites are accumulated when these nutrients become depleted. Sulphate, potassium, 
calcium, magnesium, manganese, zinc and ferric ions are also needed by microorganisms for 
growth and to provide the required osmotic potential. Organic phosphate plays a role in 
intermediary metabolism, especially as a component in "high energy" compounds such as 
adenosine triphosphate, adenosine diphosphate and arginine phosphate. Phosphate is also a 
constituent of phospholipids and nucleic acids acts as a regulator of certain enzymes in 
primary and secondary metabolism (Greasham and Herber, 1997). Sulphur is required for 
the biosynthesis of sulphur containing amino acids and certain secondary metabolites e.g. [3-
lactam antibiotics (Greasham and Herber, 1997). The remaining ions are trace elements and 
are required as co-factors and activators for many enzyme systems and as biosynthetic 
regulators of several secondary metabolites (Greasham and Herber, 1997). For marine 
microorganisms, chlorides and bromides are particularly important for metabolite 
production, and may also serve to increase the osmotic potential required for their growth. 
For example, A. umbrosus grew better in media that contained NaCl, however, for A. 
cristatum, very high salt concentration (2M) caused a decrease in growth and pigment 
production (Anke et ai., 1980a). 
4.1.3. Metabolic Profiling 
The main reason for carrying out optimisation studies is to determine the conditions for 
optimum metabolite production. The development of suitable analytical procedures to 
detect and quantify metabolites is therefore essential to this process. Metabolic profiling is a 
commonly used term to describe the methods of determining what and how many 
compounds are contained in an extract. Instruments which offer accuracy and precision are 
required for the detection and analyses of secondary metabolites. Time and cost are also 
important. Over the years, a number of research groups have developed methods for 
metabolic profiling. One group in particular, lead by Frisvad has done a great deal of work 
on fungal secondary metabolites profiling. 
chromatography (TLC), high performance 
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performance liquid chromatography-diode array detection (HPLC-DAD) and electrospray 
ionization mass spectrometry (ESI-MS). 
Although optimisation studies have been performed on E. mbmnl in terms of growth (Gould 
and Raistrick, 1934), media op timisation for metabolic creativity and metabolite productivity 
have not been investigated. The main aim of this study was to assess the affect of different 
carbon and nitrogen sources and the availability of vitamins on the metabolite production of 
our marine isolate of E. rubmnl (RUC0101). 
The objectives for this study were to: 
(a) Simultaneously optimise 
(1) production of metabolites, 
(2) incubation time and 
(3) metabolic creativity. 
Concentration data were only obtained for the two standards, flavoglaucin and physcion. 
(b) Develop an HPLC-DAD method for the metabolic profiling of E. mbmnl (RUC0101). 
4.2. Materials and Methods 
4.2.1. General Experimental 
HPLC solvents were of HPLC grade (Merck) while all extraction solvents were redistilled 
before use. Media reagents (glucose, lactose, urea, peptone, ammonium tartrate, yeast 
extract, fructose, sucrose, maltose, and mannitol) were also obtained from Merck. Seawater 
was obtained from the coastal waters of Port Alfred and was filtered before use. 
Fermentation media were autoclaved for 20 minutes at 121°C. 
4.2.2. Optimisation of Temperature and pH 
The optimum pH and temperature was determined by using growth as an indicator. The 
method used is described by Langvad (1999). A seed culture was grown by inoculating 
50mL of YPG basal medium (yeast extract, peptone, and glucose) in a 500mL Erlenmeyer 
flask with six circles (7mm diameter) of mycelial mat grown on YPG agar. The culture was 
grown at 24°C at 180rpm until mid-log phase (3 days) . Upon harvest, the inoculum was 
centrifuged at 13 OOOrpm for 25 minutes. The biomass was resuspended and washed with 
sterile seawater (50mL) and cenh'ifuged again. The biomass was thereafter resuspended in 
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30mL of sterile seawater, adjusted with either NaOH or H2S04 to the relevant pH (pH 3 - 8), 
homogenised for 3 x 0.5 second bursts and used to inoculate 96-well microtitre plates (Costar 
3595). Each plate contained 4 replicates of 180J1L YPG basal medium adjusted to pH's 3-8 
with Universal Buffer (Britton and Robinson, 1931) (Appendix A) and 4 replicates adjusted 
without buffer. 20J1L of homogenate was used to inoculate each well. The plates were 
sealed with parafilm and the four plates incubated at 20°C; 24°C; 28°C and 37°C. The optical 
density at 630nm was measured twice daily using a Powerwave X microtitre plate reader. 
4.2.3. Media Optimisation 
4.2.3.1. Experimental Design 
Six carbon sources (glucose, sucrose, maltose, lactose, mannitol and fructose), four nitrogen 
sources (peptone, yeast exh'act, urea and anunonium tartrate) and the absence/presence of 
vitamin solution (Appendix A) were used to determine the optimum medium for the 
production of secondary metabolites and metabolic creativity. Since this was a preliminary 
screening experiment, the optimisation of the concentrations of nutrients was not 
determined. All combinations of the three factors were investigated resulting in 48 
experiments, which were done in duplicate. 
4.2.3.2. Preparation of Inoculum and Cultivation 
An inoculum was prepared as described in 4.2.2. The biomass obtained from the seed 
culture was washed with sterile H20 and thereafter resuspended in 100mL of sterile sea 
water adjusted to pH = 5 with buffer. 1mL of the homogenate was used as inoculum for 
each medium. The media were made up follows: 
Nutrient Concentration 
C-source 0.5M 
N-source 5g/L 
Vitamin solution 4mL 
Buffer (Teorell and Stenhagen, 1938) 50mL 
Seawater made to 250mL 
The pH was adjusted with buffer to 5 and the solution autoclaved. Vitamin solution and 
urea were added by filter sterilisation (0.22J1m) to the relevant flasks and glucose was 
54 
Chapter 4: Optimisation a/Culture Conditions 
autoclaved separately and added to the relevant sterile media. The cultures were incubated 
at 24°C under static conditions due to the higher creativity of the fungus under these 
conditions (Chapter 2). This is consistent with results obtained by Carbone and Johnson 
(1964) who reported A. umbrosus to have better growth and more pigment per gram of 
mycelium when grown under static conditions. By inspection of the mycelial growth, the 
end of stationary phase was determined whereupon the mycelial mats were separated from 
the broth by cenlTifugation and each stored separately at -20°C until extraction. 
4.2.4. Preparation of Fungal Extr·acts for Analvsis 
The mycelia were frozen using liquid nitr·ogen and crushed using a mortar and pestle. 
Thereafter the mycelia were extr·acted sequentially with MeOH, MeOH/DCM (1:1, v/v) and 
again with MeOH. The extracts were dried in vacuo and weighed. A stock solution 
containing 1mg/ mL of crude extract was prepared in acetonitrile, for each experiment, and 
passed through a 0 .45~m filter (Millipore, U.s.A) before analysis by HPLC. 
4.2.5. Preparation of Standards 
The standards used in this section were isolated from crude extracts of RUC0101 (Chapter 5). 
Two standards were chosen: physcion (compound 1) and flavoglaucin (compound 7) and 
were used as representatives of compounds produced in each class i.e. anthraquinones and 
auroglaucin analogues respectively. 
A series of dilutions ranging from 50 - 1000flg/mL and 10 - 1000]lg/mL respectively, for 
compounds 1 and 7, were prepared and injected in duplicate using the parameters discussed 
in section 4.2.6. These concentrations were chosen in order to cover the range of peak areas 
that were produced by these compounds in the op timisation experiments. The linearity of 
both compounds was determined over the designated concentration range by linear 
regression analyses. 
4.2.6. Instrumentation and HPLC Analysis 
All analyses were done on an Agilent HP 1100 Liquid Chromatograph equipped with 
quaternary gradient pump, 1100 PDA detector, C18 ~Bondupak reversed phase column (4.6 x 
250mm) attached to a guard column (Security Guard) and a rheodyne injector (20~L sample 
loop). 20~L of a 1mg/mL sample solution were injected and the results captured on Agilent 
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ChemStation software package. The analysis was done at a flow rate of O.5mLjmin with a 
water-acetonitrile gradient starting at acetonitrile-water (40:60) for 15 minutes followed by a 
linear profile from 15 - 45 minutes to acetonitrile-water (90:10) and finally a step to 100% 
acetonitrile at which it was maintained from 45 - 55 minutes. The system was then 
equilibrated for 10 min with the starting conditions. Almost all the metabolites isolated from 
the A. glaucus group are either aromatic or have conjugated chromophores thus making their 
detection by ultraviolet spectroscopy possible. Metabolites were therefore detected at 
wavelengths of 254 and 230nm. 
4.2.7. Analysis of Results 
The metabolic creativity was calculated as described by Monhaghan et al. (1994) as the 
number of peak areas that were greater than 1 % of the total area produced by all peaks. The 
productivity was calculated from the peak areas at 254nm using a standard curve for each 
compound. 
4.3. Results and Discussion 
4.3.1. Development of HPLC Method 
Although several solvent combinations and gradients were evaluated, a mobile phase 
containing acetonitrile-water with 0.05% trifloroacetic acid gave optimum results for the 
marine isolate RUCOI0l. This is in accordance with results obtained by Frisvad and Thrane 
(1987) for the analysis of a variety of mycotoxins. Peak purity was assessed by checking the 
UV spectra of the upslope, apex and downslope of each peak. The UV spectra of physcion 
(11), isodihydroauroglaucin (2), isotetrahydroauroglaucin (3), aspergin (6), flavoglaucin (7) 
and neoechmuline A (18) were slightly different to reported values (Fig. 4.3) but this was 
expected as the absorption wavelength and maxima are influenced by the actual gradient 
composition at the moment of detection, especially in the presence of TFA (Frisvad, 1989). 
Significant variations in peak areas were observed when duplicate analyses were done on 
different days. However, percentage peak areas showed very little variation. 
I Numbers refer to that in the isolation scheme (Scheme 5.1) 
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4.3.2. Analysis of Standards 
One of the main objectives of this study was to assess how the fermentation conditions affect 
the metabolic creativity (number of compounds in the crude extract) of the fungus. In 
addition to this we also evaluated the effect of different fermentation conditions on the 
amount of flavoglaucin (7) and physcion (1) produced. These two compounds were selected 
because they were isolated in a sufficiently pure state and gave well-resolved peaks in the 
pure (Fig. 4.1 and 4.3) and crude HPLC chromatograms. These two compounds also 
represent two different classes of secondary metabolites produced by this fungus. 
Unfortunately neoechinuline A (18) did not give a well resolved HPLC peak under the 
conditions used and was not tested. Both flavoglaucin (7) and physcion (1) exhibited a linear 
relationship between area and concentration up to 1000)lg/mL (Fig. 4.2 and 4.4). The linear 
regression equations are y = 145.65 + 27.68x with correlation coefficient, 1'2 = 0.9999 for 
flavoglaucin and y = 9.36x -379.17 with r2 = 0.9855 for physcion. For areas which correlated 
to concentrations below the range of the standard curve a result of <10)lg/mL or <50)lg/mL 
for flavoglaucin and physcion respectively were reported. 
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Fig. 4.1: HPLC Chromatogram of Physcion (1) 
Table 4.1: Range of Linearity of Physcion 
Concentration (].l!1/mL) Mean Area (mAV's) 
50 
100 
200 
400 
500 
1000 
10000 1 
9000 : 
, 
8000 .J 
7000 ~ 
~ 6000 I 
<: 
E 5000 
344.5 
695.9 
1667.5 
3068.9 
3636.4 
9371.8 
%RSD 
0.0764 
0.0983 
0.0739 
0.0893 
0.0360 
0.0873 
~ 4000 . 
<" 3000 
y = 9.36x - 379.17 
r2 = 0.9855 
2000 
1000 
o . 
50 
--- --- , ---.---.---~--~~--~ 
250 450 650 850 1050 
Concentration (ug/ mLl 
Fig. 4.2: Standard Curve of Physcion 
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Fig. 4.3: HPLC Chromatogram of Flavoglaucin (7). 
Table 4 2' Range of Linearitt of Flavoglaucin ..
Concentration (pg/mL) Mean Area (mAU's) %RSD 
COMPOUND 
NAME 
Physcion (1) 
Flavoglaucin (7) 
10 
40 
80 
120 
240 
1000 
30000 -; 
25000 I 
I 
I ~~ 20000 1 C 15000 m < 10000 
5000 
o .~ 
10 210 
314.8 
1203.8 
2426.7 
3552.6 
6814.6 
27804.6 
410 610 
0.003 
0.0266 
0.0096 
0.0087 
0.0027 
0.0067 
y = 145.65 + 27.68x 
r2 = 0.9999 
810 1010 1210 
Concentration (ug / mLl 
Fig. 4.4: Standard Curve of Flavoglaucin 
Table 4 3' Retention Time and UV Maxima of Standards . . 
RETENTION UV MAXIMA (run) REPORTED UV MAXIMA (run) 
TIME 
(min) 
38.6 190;225;270;290;440 224;257;268;288;436 
44.2 210; 250; 275; 400 240;276;388 
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4.3.3. Optimisation of Media 
4.3.3.1. Influence of pH and Temperature on the Growth of RUCOI0l 
Growth was used to determine the optimum temperature and pH in order to detect which 
physical parameters caused a time decrease in the lag phase resulting in production of 
idiolites (secondary metabolites) in stationary phase. However, although these physical 
parameters may increase biomass and result in shorter incubation periods, they may affect 
the production of certain metabolites. A good way of using growth as an indicator of an 
optimum medium would therefore be to analyse the biomass by HPLC to determine if there 
is a significant effect on metabolite productivity. However due to a number of experimental 
trials, this was not feasible. 
The results obtained by using absorbance as a measurement of growth were inconsistent 
with actual onset of stationary phase. The optical density measurement is in the wavelength 
range of the visible spectrum (630nm). Therefore increases in the thickness of the mycelia 
cause an increase in the absorbance measurements. The discrepancy in the results is due to 
the production of pigments (secondary metabolites), which cause the mycelia to change from 
white to yellow to orange to red to brown. This affects the absorbance measurements by 
causing it to increase when it is actually in stationary phase. Therefore instead of optical 
density, visual inspection was used i.e. production of spores and production of reddish 
pigments known to be produced during secondary metabolism in the Aspergillus glaucus 
group (Raper and Fenell, 1965) (Fig.4.5). This method was better suited for RUCOI0l than 
optical density, although it is more subjective. However, because growth of the fungus is not 
homogenous, different regions will be in different stages of growth. Thus the conversion of a 
metabolite of interest may have already taken place in some regions while in another it is still 
being produced. 
The fungus grew best at 24°C - 27°C, pH 4 - 5 with buffer. No growth occurred at 37°C and 
growth at 20°C was slow (Table 4.4). The addition of the buffering agent increased the 
growth rate at all temperatures and ionic concentrations. These results are consistent with 
previous literature from Gould and Raistrick (1934), who found that the optimum pH for 
growth for members of the Aspergillus glaucus group was in the vicinity of neutrality with 
little or no growth above pH 8 and below pH 4 and the optimum temperature was between 
18 and 27°C with the best growth for most species at 24°C. According to Raper and Fenell 
(1965) E. rubrum grew on Czapek's solution at room temperature (24 - 26°q, and Aspergillus 
60 
Chapter 4: Preliminary Optimisation of Culture Conditions 
umbrosus, which according to Blaser (1974) is catergorised into the same group as E. rubrum 
grew best at pH 5.5 at 24°C. These conditions enabled A. umbrosus to produce the optimum 
amounts of crude secondary metabolite extracts (Carbone and Johnson, 1964). 
C8C 7C6C5C4C3 pH 
~ No Buffer 
~ With Buffer 
Fig. 4.5: RUC010l grown at 27°C with YPG Basal medium; pH range 3-8. 
C= control/blanks. 
Table 4.4: Time Taken for RUC010l to Reach Stationary Growth Phase under the Various 
Conditions 
Time (Days) 
pH Buffer 
20°C 24°C 27°C 37°C 
8 >8 >8 >8 No growth 
7 >8 >8 >8 No growth 
6 >8 5 5 No growth 
5 >8 5 5 No growth 
4 8 5 4 No growth 
3 >8 6 6 No growth 
No Buffer 
8 >8 No growth >8 No growth 
7 >8 No growth >8 No growth 
6 >8 7 7 No growth 
5 >8 7 7 No growth 
4 >8 7 6 No growth 
3 >8 >8 8 No growth 
4.3.3.2. Optimisation of Media 
4.3.3.2.1. Growth Time 
With regard to incubation time and the total amount of secondary metabolites produced, GP 
(glucose, peptone) supported the fastest growth (eight days) producing 307mg/250mL of 
crude extract as expected. In members of the A. glaucus group, this combination produced 
abundant growth but consisted of more conidia than perithecia (Gould and Raistrick, 1934). 
This was not the case here because when grown in media containing a higher carbon than 
61 
Chapter 4: Preliminary Optimisation of Culture Conditions 
nitrogen content the fungus reproduces sexually and thus more perithecia than conidia 
(asexual) are formed. SYEV (sucrose, yeast extract, vitamins) supported the highest 
production of metabolites (650mg/250mL) after 19 days of incubation. Although YPG basal 
medium still produced one of the highest amounts of crude extract (622mg/25OmL), the 
culture only reached stationary phase after approximately 25 days. With most other media, 
growth was between 11 and 13 days but these did not support high amounts of metabolite 
production, except for MYEV (453mg/250mL). Of the nitrogen sources, yeast extract and 
peptone produced higher yields than urea and ammonium tartrate, most probably due to 
these complex nutrients containing a small amount of carbohydrates, vitamins and other 
trace elements in addition to nitrogen. All carbon sources were comparable, except for 
mannitol which produced low yields. This was expected because mannitol is a slow-
utilisable sugar. 
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Fig. 4.6: Effect of Media Composition on Growth and Intracellular Metabolite Production. 
G= glucose; L= lactose; M= maltose; F= fructose; Man= mannitol; 5= sucrose; P= peptone; 
Amr- ammonium tartrate; YE= yeast extract; U= urea; V= vitamins. 
4.3.3.2.2. Analysis of Crude Extracts 
The HPLC chromatogram of RUCOI01 grown on YPG Basal Medium shows the compounds 
of interest (Fig. 4.8 - A). Although these compounds were produced when RUC0101 was 
cultivated on most of the media used, their amounts differed considerably. Therefore, the 
metabolic creativity was calculated as the number of compounds produced that elicited a 
response of more than 1 % of the total area produced by all the compounds in that extract. 
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Using this, ManP (mannitol, peptone), MAmt (maltose, ammonium tartrate) produced the 
most number of compounds (Fig. 4.7). Although flavoglaucin (7) aspergin (6), physcion (1) 
and isodihydroauroglaucin (2) were produced by the fungus in most of the media, their 
amounts were significantly different in different media. In addition a number of other 
compounds (tl1at were not isolated) were produced in one or a few of the media. 
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Fig. 4.7: Effect of Media Coml2osition on Metabolic Creativib': 
G= glucose; L= lactose; M = maltose; F= fructose; Man= mannitol; 5= sucrose; P= peptone; 
Amt= anunonium tartrate; YE= yeast ex tract; U= urea; V= vitamins. 
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(B) MUV Dow metabolic creativity), (C) ManP illustrating high metabolic creativity. 
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4.3.3.2.4. Metabolic Productivity 
Based on these estimations, SYEV (sucrose, yeast extract, vitamins), FP (fructose, peptone), 
SP (sucrose, peptone) and FYEV (fructose, yeast extract, vitamins) produced the highest 
amounts of both compounds. These amounts are better than previously found for 
flavoglaucin (7) (Gould and Raistrick, 1934). Previous reports with A. amstelodami show that 
flavoglaucin and echinuline are produced in large amounts when grown in Czapek-Dox 
medium supplemented with sucrose, and that increasing amounts of sucrose (up to 50%) 
causes an increase in the crude flavoglaucin and echinuline (Allen, 1972). Once again, low 
yields of both compounds were produced in media with urea and ammonium tartrate. 
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Fig. 4.9: Effect of Media Composition on Metabolite Production. 
G= glucose; L= lactose; M= maltose; F= fructose; Man= mannitol; S= sucrose; P= peptone; 
Amt= ammonium tartrate; YE= yeast extract; U= urea; V= vitamins. 
Due to the same medium being found to be optimum for both growth and productivity of 
physcion and flavoglaucin, it can be assumed that these nutrients cause a general increase in 
biomass of the fungus, rather than having a direct effect on the biosynthesis of them. Anke et 
al. (1980a) reported that with A. cristatum, although yeast extract produced higher mycelial 
weights, many of the anthraquinones had decreased. This might hold true for RUC0101 
because only one anthraquinone, physcion, was isolated. However the HPLC 
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chromatograms (Fig. 4.8) sh ow that another compound (retention time = 30min) that wasn't 
isolated exhibited a very similar UV spectrum to that of physcion and thus may be a related 
compound. 
Table 4.5: Summary of Optimisation Experiments 
MEDIA INCUBATION TIME PRODUCTIVITY METABOLIC 
(DAYS) (mg/L) CREATIVITY 
Flavoglaucin (7) Physcion '(1) 
ManYEV 11 76 256 21 
ManYEV 11 62 225 19 
MUV 11 11 111 23 
MUV 11 22 212 21 
LAmt 24 4 55 26 
LAmt 24 1 36 29 
FPV 14 59 228 18 
FPV 14 84 319 20 
SUV 12 5 188 20 
SUV 12 1 52 20 
ManPV 25 75 263 17 
ManPV 25 68 245 17 
LVV 13 6 41 14 
LUV 13 6 43 14 
MYEV 10 62 231 21 
MYEV 10 51 288 19 
LV 13 4 40 16 
LU 13 3 33 16 
SP 11 112 486 17 
SP 11 83 335 19 
FYEV 11 145 398 19 
FYEV 11 84 301 21 
ManP 18 3 39 30 
ManP 18 22 160 22 
MPV 16 54 251 22 
MPV 11 46 177 23 
ManYE 10 53 147 21 
ManYE 10 71 224 18 
GYEV 18 73 228 20 
GYEV 15 81 363 20 
SAmt 13 7 89 24 
SAmt 13 42 226 19 
GYE 9 38 296 19 
GYE 10 87 89 15 
GAmt 14 8 127 18 
GAmt 20 22 337 17 
GAmtV 13 11 112 20 
GAmtV 24 4 52 18 
LP 13 13 182 22 
LP 13 7 38 19 
FUV 13 7 71 19 
FUV 11 9 76 22 
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MEDIA IN CUBA TION TIME PRODUCTIVITY METABOLIC 
(DAYS) (mgfL) CREATIVITY' 
Flavoglaucin Physcion 
(7) (1) 
GP 8 76 236 22 
GP 8 69 262 21 
MU 11 16 117 25 
MU 11 8 77 17 
ManAmt 22 5 52 20 
ManAmt 13 1 6 26 
SU 13 40 285 13 
SU 13 25 167 17 
FU 13 6 169 20 
FU 14 8 153 19 
LPV 13 50 132 16 
LPV 11 39 118 18 
MAmtV 13 2 59 19 
MAmtV 14 1 58 22 
MAmt 13 1 6 24 
MArnt 13 1 52 37 
LYEV 13 83 326 30 
LYEV 13 70 320 20 
GU 13 37 293 18 
GU 14 26 203 20 
FArnt 12 2 55 20 
FAmt 13 2 64 20 
GUV 13 8 106 22 
GUV 12 10 125 16 
SArntV 23 2 78 23 
SAmtV 12 12 134 25 
FP 27 141 543 20 
FP 19 158 592 22 
SYEV 19 141 489 23 
SYEV 19 192 703 19 
MYE 10 77 269 20 
MYE 10 57 315 19 
MP 11 114 457 22 
MP 13 67 291 21 
LAmtV 13 3 56 15 
LAmtV 13 5 53 16 
FAmtV 14 1 74 25 
FAmtV 14 1 80 25 
ManU 12 2 21 16 
ManU 12 5 25 16 
FYE 8 48 205 16 
FYE 8 50 200 16 
* Metabolic crea tivity = number of compounds produced that elicited a response of more than 1 % of 
the total area produced by all the compounds in that extract. 
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4.4. Conclusion 
Although the optimisation s tudy involved a considerable amount of time (3 months from 
culturing to HPLC analyses and interpretation) these results correlate with those found for 
the Aspergillus glaucus group. Additionally, the simultaneous optimisation of (1) incubation 
time, (2) metabolic creativity and (3) metabolic productivity can be used with confidence. 
The HPLC method can be used for metabolic profiling and can be used in conjunction with 
the NMR - bioassay screening route. However some modifications such as decreasing the 
acetonitrile: wa ter ratio must be made for better separation of 0-10minutes. 
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Chapter 5: Isolation and Characterisation of Secondanj Metabolites 
5.1. Introduction 
5.1.1. Dereplication of Metabolites 
It is important to determine early on in the study of an organism if compounds produced 
have been isolated and characterised previously for bioactivity. This prevents time and 
money spent on compounds already studied. There are two general methods used for 
dereplication: 
(1) Direct comparison to reference compounds by chromatography (Borders, 1999). Rapid 
screening requires the availability of a library of reference compounds and methods for the 
simple identification of active compounds from the crude extract (Verpoorte, 1998). These 
include thin layer chromatography (TLC) and high performance liquid chromatography 
(HPLC) and hyphenated HPLC techniques such as HPLC-MS (HPLC- mass spectrometry); 
HPLC-DAD (HPLC-diode array detection) and GC-MS (gas chromatography-mass 
spectrometry). 
(2) Comparison of the chemical properties of pure compounds to those in databases and in 
literature. There are various databases available, the most comprehensive of which is the 
Chemical Abstracts Services which can be searched using SciFinder Scholar. In addition, 
MarinLit, Chapman Hall (>103 000 compounds), NAPRALERT and Beilstein contain 
information on 13C and lH nuclear magnetic resonance (NMR), infra-red spectroscopy (IR) 
and mass spectral data of natural products. Berdy (>23000), DEREP (>7 000), Antibase (>17 
000) and Kitasato (>17 000) databases are usually based on ultraviolet (UV) chromophores, 
molecular weight (MW) and general biological properties (Borders, 1999). Chapmann and 
Hall only contains information on compounds that are well characterised. Searches of this 
database utilise molecular formula (MF), MW, structure and substructures. The Antibase 
system is one of the more recent commercial databases for antibiotics and other microbial 
metabolites. The database can be searched by biological properties and UV spectra, MW, MF 
and 13C NMR signals. NAPRALERT provides information on biological properties and 
cannot be searched by MF, MW or UV chromophores (Borders, 1999). 
Although minute quantities of crude metabolites are needed by the first method, an 
adequate number of reference compounds are needed. This takes a considerable amount of 
time to build up, but works well when developed. The problem with the second method is 
that a lot of time and money is invested by (1) first purifying the "new" metabolites, (2) and 
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then attaining the various spectra for comparison. For this a few milligrams of the pure 
compounds are needed. 
5.1.2. Extraction and Purification Methods 
An important factor in determining the optimal downstream processing steps for microbial 
metabolites is the physical properties of the molecule (MW, polarity and ionic charge) 
(Borders, 1999). The microbial metabolites range from extremely water-soluble compounds 
to very organic solvent-extractable substances that have all types of ionic charges and a 
range of MW's (Borders, 1999). The most difficult to purify are the water-soluble 
compounds. Ion exchange methods are generally used for these types of compounds, 
however some may be suitable to reversed-phase chromatography. 
An important consideration is to extract the metabolites in a way that will not interfere with 
assay results e.g. if enzymes or proteins are to be assayed then special precautions need to be 
taken. Yarbrough et al. (1992) has highlighted the most common methods of metabolite 
extraction as follows: 
1. Filtration of the broth supernatant through a high molecular weight exclusion filter 
with subsequent freeze-drying 
2. Extraction of the broth with an organic solvent 
3. Extracting the broth with resins 
Depending on the solvent used in the extraction method, different quantities and different 
types of compounds can be extracted from the organism or the culture broth. Many kinds of 
extraction schemes have been designed, some highly selective for a certain group of 
compounds, others very general. In a programme screening for antitumour compounds, 
scientists at the NCI compared a series of extraction methods and found that with 
dichloromethane-methanol (1:1), all known antitumour compounds were extracted 
(Verpoorte, 1998). With all extraction methods, several primary metabolites will be extracted 
and usually in larger quantities than the secondary metabolites. In non-polar extracts for 
example, steroids and lipids will be present in large amounts, whereas in polar extracts 
sugars will be the major component (Verpoorte, 1998). Liquid extraction has been widely 
used for the extraction of secondary metabolites from fungi. Methanol, ethyl acetate, 
chloroform and dichloromethane have been used successfully to remove most of the 
secondary metabolites. The fractions of low and medium polarity can be separated by 
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normal or reversed-phase column chromatography and then by HPLC to attain the purified 
compounds. 
5.1.3. Structure Elucidation 
Once the pure compounds have been isolated, the structures are elucidated by a combination 
of Nuclear Magnetic Resonance, Mass Spectrometry and Infra Red methods. Together these 
provide a map of the carbon hydrogen framework of the organic molecule. The NMR 
techniques include lH, 13C, heteronuclear multiple bond correlation (HMBC), showing 
protons correlating to neighbouring carbons; heteronuclear multiple quantum coherence 
(HMQC), showing protons directly attached to carbons; lH-1H-homonuciear correlation 
spectroscopy (COSY) which shows proton-proton correlations; and distortionless 
enhancement by polarization transfer (DEPT), showing methines (CH), methylenes (CH2) 
and methyls (CH3). Ta ken together, these techniques make it possible to determine the 
complete structures of a compound. 
Since the Aspergillus glaucus group has been well studied, several compounds have been 
isolated and identified. Table 5.1 lists the compounds that have been identified. 
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Table 51' Secondary Metabolites Isolated from the Asvergillus glaucus GrouE ..
Metabolite: Reference: 
w-hydroxyemodin-5-methylether (HEME) (5.25) Arai et a/., 1989 
w-hydroxyrubrocristin (HRC) (5.24) Arai et a/., 1989 
Aflatoxin Bl (5.28) Leitao et al., 1989 
Asperentin (5.29) Podojil et a/., 1978 
Asperentin 8-methylether (5.30) Podojil et a/., 1978 
AsperflaYin (5.27) Arai et a/., 1989 
Aspergin (5.14) Arai et a/., 1989 
Asperinine A (5.34) Arai et a/., 1989 
Asperinine B (5.34) Arai et al., 1989 
Auroglaucin (5.17) Gould and Raistrick, 1934 
Catenarin (5.20) Anke et a/., 1980a 
Crytoechinuline G (5.12) Gatti,1978 
Echinuline (5.1) Quilico, 1964 
Emodin (5.23) Anke et a/., 1980a 
Erythroglaucin (5.20) Gould and Raistrick, 1934 
Flavoglaucin (5.13) Gould and Raistrick, 1934 
Gliotoxin (5.33) Cole and Cox, 1981 
Isoechinuline A (5.6) Nagasawa et a/., 1976 
Isoechinuline B (5.10) Nagasawa et a/., 1976 
Isoechinuline C (5.11) Nagasawa et a/., 1976 
Isodihydroauroglaucin (5.16) Arai et al., 1989 
Isotetrahydoauroglaucin (5.15) Arai et al., 1989 
L-alanyl-L-tryptophan anhydride (AT A) (5.3) Arai et a/ ., 1989 
L-alanyl-2-(1,1-dimethylallyl)-L-tryptophan Arai et al., 1989 
anhydride (ADTA) (5.2) 
Neoechinuline A (5.4) Barbetta et a/., 1969 
Neoechinuline C (5.9) Cole and Cox, 1981 
Neoechinuline D (5.5) Cole and Cox, 1981 
Neoechinuline E Cole and Cox, 1981 
Neoechinuline B (5.8) Cole and Cox, 1981 
Ochratoxin A (5.32) Cole and Cox, 1981 
Ochratoxin B (5.33) Cole and Cox, 1981 
Physcion (5.18) Gould and Raistrick, 1934 
Questin (5.19) Frisvad, 1987 
Rubrocrsitin (5.22) Anke et a/., 1980a 
Sterigmatocystine (5.31) Schroeder and Kelton, 1975 
Viocristin (5.26) Anke et a/., 1980a 
Xanthocillin Frisvad,1987 
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The objective of this study was to isolate and characterise the major secondary metabolites 
from the marine fungal isolate RUCOI0l and to use them as standards during our 
optimisation experiments and bioassays. 
5.2. Materials and Methods 
5.2.1. General Experimental 
Normal phase TLC was performed on Silica Gel 60F254 plates (Merck) and reverse phase TLC 
on RP18F254 plates. The plates were viewed under UV light (254nm). HPLC separations 
were performed using a Spectra-Series PI00 liquid chromatography pump (Thermo 
Separations), Spectra-Series UV 100 detector and a rheodyne injector equipped with either an 
analytical HPLC CIS ~Bondupak reverse phase column (4.6 x 250mm) attached to a guard 
column (Security Guard) or a preparative HPLC CI8 reversed-phase column (Phenomenex 
Luna 10~; 250 x 10mm) attached to guard column (Security Guard). 
Solvents were either of HPLC grade or were distilled before use. Fractions and pure 
compounds were dried under vacuum using a Buchi Rotavapour RE 120 or with N2 using a 
Pierce Reacti Therm Heating Module. 
The IH (400MHz), 13(: (100MHz), DEPT-135, HMQC, HMBC and COSY-90 were recorded on 
an Avance Bruker 400 MHz spectrometer using standard pulse sequences at 27°C. Either 
deuterated chloroform (CDCb) or deuterated DMSO (DMSO-d6) was used. Chemical shifts 
are reported in ppm and referenced to undeuterated solvent resonances (CHCb 8H 7.25, 8C 
77.0; DMSO 8H 2.50, 8C 39.43) and coupling constants are reported in Hz. 
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Infrared spectra were recorded on a Perkin-Elmer Spectrum 2000 FT-IR spectrometer on 
NaCl or CsCI disks. ESI-MS spectra were recorded on a Finnigan Mat LCQ mass 
spectrometer. Optical rotations were measured using a Perken-Elmer 141 Polarimeter. 
S.2.2. Isolation of Pure Metabolites 
The individual mycelial extracts (Chapter 4) resulting from the optimisation experiments 
were pooled to give a total of 109 organic material. A portion of this crude extract was 
fractionated according to Scheme S.l. Thus, 2.8g of the MeOH solubles were partitioned 
between hexane (3 x SOmL) and 10% aqueous MeOH (SSmL). Water (20mL) was added to 
the aqueous MeOH fraction which was further partitioned with DCM (3 x SOmL). The 
hexane (470mg), DCM (970mg) and aqueous MeOH (1.16g) fractions were dried over NaSO. 
(anhydrous), filtered and concentrated in vacuo. These fractions were analysed by TLC 
hexane/EtOAc (8:2) and on a RP-C18 HPLC column (Waters flBondapak, 4.S x 2S0 mm) using 
CH3CN/H20/TFA (SO: SO:O.OS) at ImL/min; 0.05 AUFS, except for the aqueous MeOH 
fraction which was insoluble in the mobile phase. Since the DCM fraction contained most of 
the compounds extracted, the pure compounds were purified from this fraction. 
800mg of the DCM extract was separated using silica chromatography (Kiesel silica gel 60) (5 
x 40cm) using a solvent combination of increasing polarity (Hexane: EtOAc, 10:0; 9:1; 8:2; 7:3; 
4:6; 6:4; 8:2; 0:1 then MeOH/DCM 1:9; 1:1; 1:0 and finally MeOH/H20 1:1; 0:1). Fractions 
were combined according to TLC analysis to give 10 fractions. Final purification was 
achieved by reversed phase HPLC (Scheme 5.1). 
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RUCOOI (48x2 fermentations) 
109 
! 
POOLED MeOH/DCM EXTRACT 
2.8g 
t SOLVENT PARTITIONING OF MeOH SOLUBLES 
HEXANE EXTRACT DCM EXTRACT _qMeOH EXTRACT 
O.Sg 19 1.2g 
I Si CHROMATOGRAPHY OF CHq SOLUBLES (800mgl 
l_ Ib Ie Id Ie If Ig Ih Ii 
48mg lOmg 20mg 64mg l1Smg 96mg 42mg 40mg 20mg 
Fr 1 Fr 2 Fr3 Fr4 FrS Fr6 Fr7 Fr 8 Fr9 
I I I 1 
l~ 0.8mg 8~ O.lmg lS~ 3.1mg IS~ 1.3mg 
2~ S.7mg 9~ <O.Smg 16~ 0.9mg 16~ <O.5mg 
3~ 3.3mg 10~ <O.Smg 17~ 0.9mg 17~ 1.7mg 
4~ 0.9111g 1l~ O.Smg 18~ 9.8mg 18~ S.6mg 
5~ 1.2111g 12~ <O.5mg 19~ 1.7mg 22~ <O.5mg 
6~ 6.8mg 13~ <O.Smg 20~<0.5mg 20~ <O.5mg 
7~ 8.1mg 14~ 0.9mg 21~ 1.6mg 21~ <O.5mg 
Scheme 5.1: Extraction and Isolation Procedure for RUC001. 
(a): 90% hexane/EtOAc; (b): 80% hexane/EtOAc; (c) 70%-60 % hexane/EtOAc; (d) 40% 
hexane/ EtOAc; (e) 20 % hexane/EtOAc; (f) 100%EtOAc; (g) 10% MeOH/CHCb; (h) 50% 
MeOH/CHCb; (i) 100% MeOH+ 50% MeOH/H20. 
I: C~CN/H20/TFA (60:40:0.05),2 AUFS; 3mL/ min; 
II: CH3CN/H20/TFA (70:30:0.05), 2 AUFS; 1mL/min; 
III: 85% MeOH/H20, 2 AUFS; 2mL/ min; 254nm; 
IV: 80% MeOH/H20. 
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5.3. Results and Discussion 
5.3.1. Extraction and Isolation 
The crude mycelial extract from the 96 fermentations were pooled (2.8g) resulting in a blood-
red extract that showed several interesting signals at 6 12, 6 10, 6 5 -7 and 6 2-4 in the 'H 
NMR spectrum. The crude extract was fractionated according to Scheme 5.1. Solvent 
partitioning experiments showed that the DCM fraction contained a number of compounds 
that were present in the crude fraction. Silica chromatography of this fraction (800mg) 
produced nine further fractions, which were then purified by HPLC. The non-polar fractions 
(a-f) were yellow becoming red while the polar fractions (g-i) were red-brown in colour. The 
latter could not be separated due to its high polarity. Although 22 compounds were isolated, 
only six compounds physcion (compound 1), isodihydroauroglaucin (compound 2), 
isotetrahydroauroglaucin (compound 3), aspergin (compound 6), flavoglaucin (compound 7) 
and neoechinuline A (compound 18) were pure enough and isolated in sufficient quantity for 
their structures to be elucidated. Furthermore, the quantities of pure compounds isolated 
from the DCM fraction are not representative of the total amount contained in the mycelial 
crude extracts. A better indication of the quantities produced by both physcion and 
flavoglaucin can be obtained using the optimisation experiments (Chapter 4) . 
5.3.2. Structure Elucida tion 
5.3.2.1. Compound 7 
It was evident from the 'H, 13C and mass spectrum of compound 7 that there were 19 
carbons, 28 protons and 3 oxygens. The 19 carbon resonances were attributable to 6 x C; 3 x 
CH; 7 x CH2 and 3 x CH3 (Table 5.2). The 'H NMR spectrum (Fig. 5.2) showed typical signs 
of an isoprenyl group with signals at 61.69 (3H, s); 6 1.75 (3H, s); 6 3.28 (2H, d, J = 7Hz) and 
6 5.36 (lH, t). A strong 'H NMR Signal at 6 10.24 suggested the presence of an aromatic 
aldehyde, which was confirmed by the IR spectrum containing a band at 1628cm-1. Also 
present in the 'H NMR spectrum were two exchangeable protons s at 6 11.9 (lH, 2-0H, 
hydrogen bonded) and 0 4.3 (lH, br, 5-0H) as well as an aromatic proton (6 6.88, s). This 
confirmed the presence of the three oxygens two as OH's and one as a carbonyl. The UV 
maxima at 250nm supported the presence of an aromatic ring. The remaining protons (60.88 
- 1.6) were contained in an aliphatic chain. HMBC correlations were used to position the 
different groups on a pentasubstituted aromatic ring (Fig. 5.4). Key HMBC correlations are 
79 
Clzapler 5: Isolation and Clzaracterisation of Secondan; Metabolites 
shown in Fig. 5.3. Strong and unambiguous HMBC correlations (Fig. 5.4) from the phenolic 
OH at 0 11.9 (2-0H) to signals at 0 117.3 (C-1), 155.8 (C-2) and 128.5 (C-3) and from the 
methylene at 0 2.87 to signals at 0 128.5 (C-6), 117.3 (C-1) and 144.9 (C-5) were particularly 
useful. The remaining signals could only be accommodated in a heptyl chain. This 
structure complies with that of flavoglaucin (5.13) with all spectroscopic data in agreement 
with previous results (Podojil et aI., 1978; Allen and Barrow, 1977) . 
" 
, 
" 
, 
, 
" OH 0 
I" 
OH 
" 
• 5 4 
Fig. 5.2: lH NMR Spectrum of Compound 7 (CDC!,; 400MHz). 
Fig. 5.3: Key HMBC Correlations 
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Fig. 5.4: HMBC Spectrum of Compound 7 
Flavoglaucin has previously been isolated from several members of the A. glaucus group and 
shown to be cytotoxic (Kawai et al., 1983), possess antioxidant properties (Ishikawa et aI., 
1984; Tanaka et aI., 2001) and antimicrobial properties (Betina et al., 1981). Its structure was 
originally determined by chemical degradation and synthesis of a reduced intermediate 
(Raistrick et al., 1937; Cruickshank et aI., 1938 and Ashley et al., 1939). Biosynthetic studies 
have shown that flavoglaucin is a regular polyketide which is modified by isoprenylation 
(Allen and Barrow, 1977). The putative acyclic biosynthetic precursor of flavoglaucin is 
shown in Fig. 5.5. 
o 0 
Fig. 5.5: Acyclic Precursor of Flavoglaucin 
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Table 5.2: Spectral Data for Compound 7 in CDC!,. 
Atom no. oe DEPT OR [mult., J (Hz)] COSY 
1 117.3 qC 
2 155.8 qC 
3 128.6 qC 
4 125.7 CH 6.88, S 2-0H (lr), H-14 (lr) 
5 144.9 qC 
6 128.5 qC 
7 23.9 CH2 2.87, t,7.6 H-9; H-19 (Ir) 
8 29.1 CH2 1.39, m H-9 
9 31.9 CH2 1.57, m H-8; H-7 
10 29.6 CH2 1.39, m H-9 
11 31.8 CH2 1.27, m H-13 
12 22.6 CH2 1.27,m H-13 
13 14.0 CH3 0.88, t, 6.8 H-ll 
14 27.0 CH2 3.28, d, 7.4 H-17 (Ir); H-15, H-4 
15 121.1 CH 5.26,br t,7.4 H-14; H-17 (Ir) 
16 133.8 qC 
17 25.8 CH3 1.75, S 
18 17.8 CH3 1.69, S H-14; H-15 
19 195.5 CH 10.24, S 
2-0H 11.9, S 
5-0H 4.3,br S 
5.3.2.2. Compound 6 
HMBC 
C-14; C-3; C-4 
C-10; C-9; C-1; 
C-3; C-4 
C-7; C-17; C-3 
C-13; C-12; C-11 
C-15; C-6; C-16 
C-18; C-14 
C-3; C-4 
C-17; C-15; C-16 
C-l ; C-6; 155.8 
A comparison of the lH NMR spectra of Compounds 6 and 7 immediately suggested that the 
two were related. The lH NMR spectrum of compound 6 (Fig. 5.6) showed two 
exchangeable protons at 8 11.7 (lH, 2-0H) and 8 4.96 (lH, br, 5-0H); an aldehyde proton at 8 
10.09 (lH, s) and signals which corresponded to a dimethylallyl moiety [85.28,t; 8 3.30,d; 8 
1.75,s; 8 1.69, sJ. The two additional signals at /)6.46 (lH, d, J=16.4Hz) and 8 5.97 (lH, dt, J = 
6.9Hz) therefore indicated unsaturation in the heptyl side chain. The low resolution mass 
spectrum of compound 6 showed a molecular ion peak at m/z 302 also suggesting that 
compound 6 is a dehydro derivative of flavoglaucin. An analysis of HMBC data confirmed 
the structure of the prenylated 2,5-dihydroxybenzaldehyde skeleton and also clarified the 
position of the double bond in the heptyl side chain. The doublet at /) 6.46, showed HMBC 
correlations to signals at 8 117 (C-1), 123 (C-6) and 144 (C-5) thus indicating that the double 
bond is between C-7 and C-8. This structure is consistent with that of aspergin (5.14) 
previously isolated from an unidentified Aspergillus sp. (Sokolov et al ., 1971). 
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Fig. 5.6: 'H NMR Spectrum of 6 (CDC!.,: 400MHz). 
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Table 5 3' SI1ectral Data of 6 in CDCh ..
Alom oc DEPT 0 .. [mult., J (Hz)) COSY HMBC 
1 117.3 qC 
2 155.1 qC 
3 130.4 qC 
4 125.1 CH 7.01, S H-14; 2-0H C-14; C-3; C-5 
5 144.8 qC 
6 123.9 qC 
7 120.1 CH 6.46, d, 16.4 H-14; H-8 C-9; C-1; C-6; C-5 
8 142.7 CH 5.97, dl, 16.0, 9 H-14; H-7 C-9 
9 33.4 CH2 2.30,m H-I0; H-8;H-7 C-8; C-7 
10 28.7 CH2 1.5, m H-14 
11 31.4 CH2 1.25,m 
12 22.4 CH2 1.35, m H-13 
13 13.99 CH3 0.92, t, 7 H-12 
14 27.2 CH2 3.3, d, 7.2 H-18; H-15; C-2 
H-4 
15 121.0 CH 5.28, I, 6.9 H-14; H-18; C-18; C-17 
H-18 
16 133.9 qC 
17 25.8 CH3 1.75, S C-15 
18 17.8 CH3 1.69, S H-14; H-15 C-15 
19 196.3 CH 10.09, S C-2; C-l; C-6 
2-0H - - 11.7, S C-3; C-2 
5-0H - - 4.96, br S 
5.3.2.3. ComI1ound 2 
The IH NMR spectrum of compound 2 (Fig. 5.7) showed signals at 1) 11.9 (2-0H), 810.22 (lH, 
s, aldehyde), 8 6.89 (lH, s), 8 5.27 (lH, br t), 8 3.28 (2H, d, J ~ 7.2), /) 1.75 (3H, s) and 81.68 (3H, 
s), which immediately suggested a prenylated 2,5-dihydroxybenzaldehyde derivative. 
Additional signals at 8 6.01 (2H, br m) and 8 5.59 (2H, br m) indicated the presence of two 
double bonds in the heptyl side chain. COSY and HMBC correlation data confirmed the 
structure of the prenylated 2,5-dihydroxybenzaldehyde moiety and assisted in positioning 
the two double bonds. The methylene at 8 2.97 (2H, t, J~7.2) showed HMBC correlations to 
signals at 8 117.3 (C-1), 8 145.0 (C-5) and 8 128.9 (C-6) as well as COSY correlations to a 
methylene at /)2.33 (2H, br m) thus indicating the presence of a -CH2CH,- moiety at C-7 and 
C-8. The two double bonds can only therefore be accommodated at C-9 and C-ll (Fig. 5.7, 
Table 5.4). All the spectroscopic data are in agreement with the sh'ucture of 
isodihydroauroglaucin (5.16), which had previously been reported from A. chevalieri 
(Hamasaki et a/., 1980). 
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Fig. 5.7: 'H NMR Spectrum of 2 (CDCh; 400MHz). 
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Table 5.4: Spectral Data of Compound 2 in CDC)' 
Atom 8e DEPT 8H [mult., 1 COSY HMBC 
1 117.3 qC 
2 155.9 qC 
3 127.4 qC 6.89, S H-14; H-19 
4 125.8 CH 6.89, S H-14; H-19 C-3; C-5 
5 145.0 qC 
6 128.9 qC 
7 24.6 CH2 2.97, t, 7.2 H-8 C-1; C-5; C-8 
8 34.2 CH2 2.33, br m H-13; H-9; H-7; H-11 C-9; C-10 
(lr) 
9 129.3 CH 5.59, br m H-8; H-11 C-8 
10 132.0 CH 6.01, br m H-8; H-9, H-11 C-8 
11 131.1 CH 6.01, br m H-8; H-9; H-11 
12 128.3 CH 5.59, br m H-13; H-8; H-11 C-13 
13 17.8 CH3 1.72, m H-8; H-9; H-11 C-12 
14 27.0 CH2 3.28, d, 7.2 H-17; H-7; H-9; H-11 C-15; C-16; C-3 
(lr); H-15; H-3, H-4 
15 121.1 CH 5.27, br t, 9.8 H-17; H-14 
16 133.9 qC 
17 26.5 CH3 1.75, S H-8; H-14; H-15; H-9; C18; C-16; C15 
H-11 
18 18.0 CH3 1.68, S 5.29; H-14 C-17 
19 195.4 CH 10.22, S C-2; C-1; C-6 
2-0H 11.9, S C-13; C-2; C-19 
5-0H 4.96, br, 5 
5.3.2.4. Compound 3 
The final compound isolated in this series was compound 3 (Fig. 5.8). The presence of the 
prenylated 2,5-dihydroxybenzaldehyde moiety was confirmed by the observation of signals 
at Ii 11.91 (1H, 2-0H), Ii 10.23 (1H, s), Ii 6.88 (1H, s), Ii 5.28 (3H, m), Ii 3.28 (2H, d, I = 7.3), Ii 
1.75 (3H, s) and Ii 1.69 (3H, s). In addition, the methyl group at Ii 0.92 (cf flavoglaucin) has 
disappeared and a new peak at Ii 1.63 (3H, d, J= 4.5) appeared. It was therefore obvious that 
this compound contained a double bond at C-12. HMBC data supported this structure 
(Table 5.5). Isotetrahydroauroglaucin (compound 3) (5.15) has previously been reported 
from A. ruber (Hamasaki et al., 1980). 
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Fig. 5.8: lH NMR Spectrum of Compound 3 (CDCbj 400MHz). 
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Fig. 5.9: HMBC Spectrum of Compound 3 
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Table 5.5: Spectral Data for 3 in CDCh 
Atom Dc DEPT OR [mult., J (Hz)] COSY HMBC 
1 117.3 qC 
2 155.8 qC 
3 128.3 qC 
4 125.9 CH 6.88,5 C-6; C-5 
5 144.9 qC 
6 128.3 qC 
7 24.3 CH2 2.87, t,7.8 H-8 C-8 
8 31.3 CH2 1.57, t, 8 H-7 
9 32.3 CH2 1.4, m H-I0 
10 29.7 CH2 2.05,5 H-9 
11 130.9 CH 5.28, m 
12 125.7 CH 5.28, m C-13 
13 17.9 CH3 1.63, d, 4.5 C-4 
14 27.0 CH2 3.28, d, 7.3 H-11, H-12 C-15 
15 128.7 CH 5.28, m H-14 
16 133.8 qC 
17 25.8 CH3 1.75,5 C-16 
18 17.8 CH3 1.69,5 C-16 
19 195.9 CH 10.23,5 C-1; C-3; C-2 
1-0H - - 4.3, brl 5 
2-0H - - 11.91,5 C-l; C-2; C-3 
5.3.2.5. Compound 18 
The lH NMR spectrum of compound 18 was significantly different from the ones previously 
discussed. The J3C NMR spectrum of compound 18 showed the presence of 19 carbon 
signals of which 14 were Sp2 hybridized (Fig. 5.12; Table 5.6). The lH NMR spectrum (Fig. 
5.10) showed signals for_seven vinylic methine signals at 0 7.42 (lH, d, J = 8 Hz), 0 7.17 (lH, 
d, J = 7.6 Hz), 0 7.08 (lH, t, J = 7.4), 0 7.00 (lH, t, J = 7.4), & 6.89 (lH, s), 06.06 (lH, dd, J = 17, 
10 Hz) and 0 5.01 (2H, dd, J = 17, 10 Hz), three methyl signals (01 .47, 6H, sand & 1.37, 3H, d, J 
= 6.8 Hz). J3C NMR resonances at 0126.0,135.1,111.7,120.0,119.5 and 118.9 together with a 
broad exchangeable proton at & 11.0 in the lH NMR spectrum suggested the presence of an 
indole (Pretsch et aI., 2000) which was unsubstituted in the benzene ring. This substructure 
assignment was supported by an IR absorption band at 3360cm-1 and UV maxima at 230 and 
290nm. Two amide groups were also deduced from J3C signals at 0 166.6 and 160.0 and IR 
absorption bands at 1670 and 1630 cm-l. The above information together with a molecular 
ion peak at m/ z 323 in the low resolution mass spectrum suggested a molecular formula of 
C19H21N302 and 11 degrees of unsaturation for compound 18. HMBC and COSY-90 data 
were useful in determining the structure of compound 18. The indolic proton at & 11.0 
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showed HMBC correlations to signals at 8144.1 (C-2), 135.1 (C-7a) and 103.4 (C-3) indicating 
that the indole ring was substituted at positions 2 and 3. An isopentenyl substituent at C-2 
was deduced from a COSY correlation between the terminal methylene (8 5.03) and the 
methine at 8 6.06 and HMBC correlations from the two methyl groups at I) 1.47 to carbon 
signals at 8 111.7 (C-l7) and 144.1 (C-2). A 2,5-diketopiperazine ring was inferred from 
HMBC correlations from the proton at 88.61 NH-13 to carbons at 8 160.0 (C-14) and 50.6 (C-
12) and from the NH-10 to carbons at 8 166.6 (C-11) and 103.4 (C-3). HMBC correlations 
from the vinylic proton at 86.89 (H-8) to carbons at 144.1 (C-2) indicated that this substituent 
was attached to the indole ring at position 3. This structure together with all the 
spectroscopic data comply with that of Neoechinuline A (5.4) (Gatti and Fuganti, 1979; Cole 
and Cox, 1981) . 
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Fig. 5.11: BC NMR Spectrum of 18 (100MHz; DMSO-d6) 
Fig. 5.12: Key HMBC Correlations of Compound 18 
Neoechinuline A is a structurally related dehydrotryptophan derivative of echinuline, an 
isoprenylated tryptophan derivative that was isolated from A. amstelodami. Birch et al. (1961) 
and Birch and Farrar (1963), have clearly established that the biosynthetic precursors of 
echinuline are tryptophan, alanine and mevalonic acid. It has been further established that 
L-tryptophan and cyclo-L-alanyl-L-tryptophanyl are in vivo precursors of echinuline (Allen, 
1972). 
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Table 5 6, Sl2ectral Data for Compound 18 in DMSO d6 .. -
Atom lie DEPT IiH [mult., J (Hz)) COSY HMBC 
1-NH 
- - 11 .10, s C-3a; C-3b; C-7b; C-2 
2 144.1 qC 
3 103.4 qC 
4 118.9 CH 7.17, d, 7.6 C-3a; C-6;C-7b 
5 119.5 CH 7.00, t, 7.4 H-5 C-7; C-3b 
6 120.9 CH 7.08, t, 7.4 C-8; C-4; C-7b 
7 111.7 CH 7.42, d, 8 C-4; C-3b 
3. 126.0 qC 
7. 135.1 qC 
8 110.4 CH 6.89,5 C-3b; C-2; C-14; C-11 
9 124.8 qC 
14 160.0 qC 
13-NH - - 8.61,5 C-8; C-9; C-14; C-11 
12 50.6 CH 4.15, q, 6.4 H-20 C-14; C-11 
11 166.6 qC 
10-NH - - 8.20,5 C-9; C-ll 
20 19.7 CH3 1.37, d, 6.8 H-12 C-ll 
15 40.2 qC 
18 27.5 CH3 1.47,5 C-7; C-2 
19 27.5 CH3 1.47,5 C-7; C-2 
16 145.2 CH 6.07, dd, 17, 10 H-17 C-2 
17 111.7 CH2 5.03, dd, 17, 10 H-16 C-16 
5.3.2.6. Coml2ound 1 
The lH NMR spectrum of compound 1 (Fig. 5.13) showed two exchangeable proton signals 
[8 12.3 (lH, s, 8-0H) and 0 12.1 (lH, s, 1-0H)], four aromatic me thine signals [07.63 (lH, s, 
H-4); 0 7.38 (lH, d, J = 2.8 Hz, H-ll); 0 7.08 (lH, s, H-2) and 0 6.69 (lH, d, J = 2.8 Hz, H-7) and 
two methyl signals [0 3.94 (3H, s, 6-0CH3) and 0 2.45 (3H, s, 3-C~)]. Not all the carbons 
were immediately discernable in the 13C spectrum because of the small amount of material 
isolated. Here, careful comparison of the DC spectrum with the HMBC spectrum (Fig. 5.15) 
was used to identify the remaining quaternary carbons (mainly carbons at ring junctions). 
Fourteen of the sixteen carbons for compound 1 were sp2 hybrizided and immediately 
suggested a polycyclic structure. Carbon signals at 0 190.8 (C-9), 0 182.2 (C-I0), 0 166.6 (C-6), 
o 165.2 (C-l), 0 162.5 (C-8) and 0 22.2 (3-CH3) in addition to a strong infrared absorption at v 
=1619cm-1 were typical of a trihydroxyanthraquinone structure of the emodin class. Careful 
analysis of the HMBC data (Table 5.7) allowed the positioning of the two hydroxy Is, the 
methoxyl and the methyl substituents. A literature search indicated the compound 1 was 
identical to physcion which had also been previously reported from the genus Aspergillus 
(Anke et al., 1980a; Engstrom et al., 1980), as well as the lichen Xanthoria (Manojlovic et aI., 
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2000) and higher plant species (Turner, 1971). Physcion (5.18) has been found to exhibit 
various activities such as antibacterial and anti-fungal activities (Podojil et aI., 1978) and act 
as a sunscreen agent (Wynn-Williams et aI., 2002). 
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Fig. 5.13: lH NMR Spectrum of 1 (CDCh); 400MHz). 
Fig. 5.14: Key HMBC Correlations of Compound 1 
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Fig. 5.15: HMBC Spectrum of Compound 1 
Table 5.7: Spectral Data for 1 in CDCb. 
DEPT IiH [mult., J (Hz)] COSY HMBC 
qC 
CH 7.0S, s H-5, H-4 
qC 
CH 7.63, s H-5, H-2 C-2 
qC 
CH, 2.45,5 H-2 C-3; C-2 
qC 
CH 6.69, d, 2.8 H-11 C-Sa 
qC 
qC 
qC 
qC 
qC 
CH 7.3S, d, 2.8 H-7 
CH30 3.94,5 C-6 
-
12.1, s 1C-9a; C-1 
-
12.3, S C-Sa; C-S 
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5.4. Summary and Conclusion 
Six known compounds were isolated from mycelial extracts of the marine derived fungus of 
the genus Eurotium. The structures were determined by interpretation of spectral data and 
comparison with literature values. The fact that only known metabolites were isolated 
highlights the problem faced by all natural product chemists involved with the isolation of 
natural products from microorganisms. The rapid dereplication of known metabolites is 
therefore essential for natural products research. 
It is interesting to note that the metabolites are of polyketide, terpenoid and shikimate origin. 
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Chapter 6: Biological Screening 
6.1. Introduction 
The last stage of a natural products screening programme is to determine whether metabolites 
isolated exhibit biological activity. There are a number of screens available and with the advent 
of genomic sequencing, new molecular targets are available for cell-based assays. Determining 
which screens to use is difficult. However, when pure compounds are available, the biological 
activity of a compound may be predicted by analysis of its structure. Nevertheless, the 
bioactivies of many compounds go unrecognised because of the limited number of assay 
systems being used in the average natural products research group. One of the major 
limitations is the insolubility of compounds in an assay (Dr Gustafson, 2002). Although 
techniques such as rocking and sonicating are employed, many of the compounds may 
precipitate out of solution as the experiment progresses. The other difficulty is that there may 
be insufficient amounts of the compound for testing. However the shift to use of bioassays in 
microtitre plates (which require microgram quantities) is now a common practice. Assays also 
need to be robust to avoid false positives yet sensitive enough to avoid false negatives (which 
rarely get a second chance). 
The metabolites from the Aspergillus glaucus group have been shown to possess various 
biological activities. Anthraquinones in particular possess astringent, purgative, anti-
inflammatory and antiviral activity with moderate antitumour and bactericidal effects 
(Manojlovic et aI., 2000). Anthraquinones chrysophanol, physcion (1), erythroglaucin, emodin, 
catenarin, and viocristin have antibacterial and anti-fungal activities (Podojil et al., 1978; Anke e/ 
aI., 1980b; Agarwal et al., 2000; Babu et aI., 2003). In addition, physcion has been suggested to act 
as possible sun-screen agent (Wynn-Williams et aI., 2002; Gauslaa et al., 2003; Solhaug et aI., 
2003). Emodin has antioxidant activity (Ng et aI., 2003) and recently showed cytotoxicity 
towards human oral squamous cell carcinoma (HSC-2) salivary gland tumor (HSG) cell lines 
(Shi et aI., 2001) and human cervical cancer cells (Srinivas et al., 2003). The auroglaucin 
analogues also possess antioxidant properties and antibiotic activities (Podojil e tal., 1978a; 
Ishikawa et al., 1984, Tanaka e/ al., 2001) and echinuline is active against Mycobacterium 
tuberculosis (Kanokmedhakul et al., 2002). Neoechinuline A (18) possesses antioxidant activity 
(Yagi and Doi, 1999). While these metabolites do exhibit activities that are beneficial to humans, 
echinuline and erythroglaucin have been shown to be toxic (Wells et aI., 1975; Ali et al., 1988; 
Meuller et al., 1999; Chen et aI., 2002). Carcinogens are also a COmmon occurrence e.g. 
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sterigmatocystin, (Schroeder and Kelton, 1975,) and aflatoxin B1 (Leitao et aI., 1989) ochratoxin 
and gliotoxin (Turner, 1971). 
Since the main focus of our research is the search for antibacterials and anticancer agents, these 
screens were chosen. 
Brine-shrimp Assays (Artemia salina, Leach) 
The brine-shrimp lethality assay was proposed by Michael (1956) and later developed by 
Vanhaecke et al. (1981) and Sleet and Brendel (1983). Due to most anti-tumour compounds 
being cytotoxic, the brine-shrimp lethality test is used as a prescreen for potential anti-cancer 
compounds. The brine-shrimp assay has been shown to give good correlation (p=0.036) with 
the 9KB cytotoxicity assay (Anderson et aI., 1991). Brine-shrimp have also been used in other 
bioassay systems such as testing for mycotoxins (Brown and Wildman, 1968; Harwig and Scott, 
1971), toxic marine products (Carballo et aI., 2002), presence of heavy metals and cyanobacterial 
toxins (Carballo et aI., 2002) pesticide residues, stream pollutants, anaesthetics, dinoflagellate 
toxins, morphine-like compounds, determining toxicity of oil dispersants, cocarcinogenicity of 
phorbol esters and toxicants in marine environments (Meyer et al., 1982). Thus the assay is not 
specific for the detection of antiturnour compounds, however, it is used as a preliminary test 
assay because (1) it is simple (neither aseptic techniques nor the need for maintaining cultures), 
(2) is not time-consuming and (3) utilises a large number of easily available organisms required 
for statistical purposes. Furthermore, the eggs remain viable for several years when stored dry 
and the hatching is attained w ithin 24 hours (Michael, 1956; Meyer et al., 1982). The method also 
requires no special equipment or training and a relatively small amount of test sample is needed 
(Meyer et aI., 1982). The use of this system in micro titre plates makes it possible to test large 
numbers of samples in replicates at different concentrations with only small amounts (0.6mg) of 
the test sample being needed (Solis et al., 1992). 
Using the brine-shrimp cytotoxicity assay, antibiotic assay and crystal violet cytotoxicity assay, 
the bioactivity of the fractions as well as the pure compounds, flavoglaucin (compound 7), 
aspergin (6), isodihydroauroglaucin (2) neoechinuline A (18), physcion (1) and 
isotetrahydroauroglaucin (3) were determined. These methods were also evaluated to 
determine if the bioassays should be included in further screening processes. 
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6.2. Methods 
6.2.1. General Experimental 
See chapter 2. 
6.2.2. Antibiotic Assays 
The crude mycelial extract, solvent partitions and pure compounds were tested in duplicate 
against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Bacillus subtilis and 
marine bacteria Vibrio alginolyticus, Alteromonas salmonicida and A. hydrophila. 150JlL of an 
overnight culture of the test microorganisms cultivated in nutrient broth were used to inoculate 
the surfaces of nutrient agar plates (Appendix A) . The plates were dried before circular disks 
(Whatmann No.1; 5mm diameter) containing the crude fractions (200Jlg) and pure compounds 
(100Jlg) were placed on them. Streptomycin sulphate (25Jlg) (Novo-Nordisk) and Penicillin 
(25Jlg) (Penilente-Forte) were used as positive controls for gram-positive and gram-negative 
bacteria respectively. Disks containing the relevant solvents used for transfer of samples were 
used as negative controls. All experiments were done in duplicate. Plates containing E. coli and 
S. aureus were incubated at 37°C and P. aeruginosa and B. subtilis at 30°C overnight. Zones of 
inhibition (in millimeters) indicating anti-bacterial activity were measured. 
6.2.3. Cytotoxicity Assays 
Brine shrimp were hatched as described in section 2.2.7. 75pL of seawater was added to the 
wells B-D in the micro titre plate. 100pL of 10mg/mL solution of each extract and pure 
compound in absolute EtOH was transferred to 650pL of seawater to give a concentration of 
1mg/750pL. 150pL of this solution was added to well A. Serial dilutions were made by 
transferring 75pL from well A to B, and then from B to C, and finally from C to D. 75pL of sea 
water was added to all wells. 100pL of seawater containing 10 - 20 nauplii were added to each 
well. Final sample concentrations were therefore 400pg/mL (well A); 200pg/mL (well B); 
100pg/mL (well C) and 50pg/mL (well D). The plates were stored in the dark overnight and 
thereafter the dead nauplii were counted. 100pL MeOH was added to all wells and after 20 
minutes the total number of nauplii in all wells was counted. Experiments were done in 
duplicate with solvent controls. 
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6.2.4. Anti-cancer Assays 
Crystal Violet Cytotoxicity Assay was performed according to Chapter 2.3.8. 
6.3. Results and Discussion 
6.3.1 Antibiotic Assays 
Although metabolites of E. rubrurn have been reported to exhibit antibiotic activity against a 
range of bacteria, in our screens, they did not exhibit any activity against any of the marine 
bacteria, E. coli, S. aureus, P. aeruginosa, and B. subtilis however all test pathogens were sensitive 
to the positive controls at 25j1g. In experiments done by Podojil et al. (1978), echinuline, 
physcion (1), erythroglaucin and flavoglaucin (7) were not effective against B. subtilis or 
Pseudomonas ovalis when grown on rich media. Possible reasons for the lack of activity include 
(a) failure of the test compounds to diffuse into the surrounding aqueous based medium; (b) the 
compounds may not be active against these specific strains; (c) microbes may be resistant to the 
compounds when grown in nutrient agar. 
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Table 6.1: Zones of Inhibition resulting from Antibiotic Assays (mm) 
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Crude extract 0 0 0 0 0 0 0 
Hexane fraction 0 0 0 0 0 0 0 
ag. MeOH fraction 0 0 0 0 0 0 0 
DCM fraction 0 0 0 0 0 0 0 
Fraction 1 0 0 0 0 0 0 0 
Fraction 2 0 0 0 0 0 0 0 
Fraction 3 0 0 0 0 0 0 0 
Fraction 4 0 0 0 0 0 0 0 
Fraction 5 0 0 0 0 0 0 0 
Fraction 6 0 0 0 0 0 0 0 
Fraction 7 0 0 0 0 0 0 0 
Fraction 8 0 0 0 0 0 0 0 
Fraction 9 0 0 0 0 0 0 0 
Aspergin 0 0 0 0 0 0 0 
Flavoglaucin 0 0 0 0 0 0 0 
Neoechinuline A 0 0 0 0 0 0 0 
lsodihydroauroglaucin 0 0 0 0 0 0 0 
lsotetrahydroauroglaucin 0 0 0 0 0 0 0 
6.3.2. Brine Shrimp Cytotoxicity Assays 
Not all compounds couId be tested due to the small amounts isolated. Of the extracts tested, the 
crude, hexane and OCM partitions, and fractions 1, 2, 5 and 6 showed cytotoxic activity. The 
aqueous MeOH fraction did not exhibit any activity even at the highest concentration 
(400jlgjmL), while the OCM fraction produced the highest activity (Fig. 6.1). It is also apparent 
that pure compounds possess stronger activity than when in a crude mixture e.g. compounds 
isodihydroauroglaucin (2) and isotetrahydroauroglaucin (3), isolated from fractions 1 and 2, and 
neoechinuIine A (18) from fractions 5 and 6 exhibited higher activities. 
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6.3.3. Anti-cancer Results 
The Hexane and OCM partitions, fractions 1 and 6 fractions as well as isodihydroauroglaucin 
(2), isotetrahydroauroglaucin (3) and neoechinuline A (18) were active against both cervical and 
oesophageal cells at lOp.gj mL. These results correlate well with the brine shrimp results. 
6.4. Summary and Conclusion 
These results show us that neoechinuline A, isodihydroauroglaucin and 
isotetrahydroauroglaucin (3) show potential for their use as chemotherapeutic agents against 
oesophageal and cervical cancers. The methods used here are simple enough to be carried out 
by a natural product chemist, however when working with highly pathogenic microorganisms 
and facilities do not permit the execution of tests, outsourcing is an option. The combination of 
general and specific bioassays with chemical screening is thus essential for the screening natural 
products. 
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Chapter 7: Final Conclusions 
7.1. Summary of Findings 
The use of various isolation media is essential to a natural products programme as it has 
been shown to result in the isolation of different fungi and thus increase the chances of 
finding new microorganisms that produce new metabolites for testing. 
Culture conditions i.e . static and shaken, produce significantly different metabolites and 
therefore it is essential to investigate the effects of these culture conditions on an unknown 
microorganism. 
By using a combination of chemical (lH NMR) and biological methods (bioassays) screening 
RUC0101 was chosen for further study. Using DNA analyses of the ITS1 region, RUC0101 
was identified as a close relative of Eurotium rubrum (Aspergillus ruber). 
In order to assess the metabolic creativity of an organism, various fermentation media were 
employed. Complex nitrogen sources such as yeast extract and peptone had the largest 
effect on productivity and growth. However, YPG Basal Medium induced one of highest 
productivities of both physcion and flavoglaucin, and the highest creativy. The HPLC 
method developed for the analyses of creativity and productivity can also now be used for 
further metabolic profiling and can be used in conjunction with the NMR-bioassay screening 
method. 
Although 22 compounds were isolated using semi-preparatory HPLC, only six compounds 
were in sufficient quantity and sufficient purity for structure elucidation using NMR. These 
six included physcion, neoechinuline A, flavoglaucin, aspergin, isodihydroauroglaucin and 
isotetrahydroauroglaucin, which are all known metabolites produced by the A. glaucus 
group. 
The preliminary biological assessment of the compounds isolated show that neoechinuline 
A, isodihydorauroglauin and isotetrahydoauroglaucin show potential as chemotherapeutic 
agents against cervical and oesophageal cancers. 
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7.2. Recommendations 
The purpose of this project was to develop and evaluate methods for the discovery of natural 
products from marine fungi. This study revealed a number of organisational and technical 
issues. 
It is important early on in the study to identify the isolate. With the advent of DNA analyses 
using the ITS regions of rDNA, genetic identification is more reliable than taxonomy or 
chemotaxonomy, however it is expensive and takes time especially when PCR requires 
optimisation. 
The simultaneous optimisation of creativity, productivity and incubation time can be 
achieved through one experiment. However optimisation is not essential in the early stages 
of development, especially if a specific metabolite is not being investigated 
Extraction of metabolites using solvent extraction has a turnaround time of one day per 
sample. The purification of metabolites using column chromatography and HPLC may also 
require time depending on the concentration of compound and its polarity. The bottleneck 
with regard to the structure elucidation of metabolites is not in the method, but in the 
analyses. Structure elucidation is essentially experienced-based and requires an extensive 
background. 
The discovery process is undeniably time-consuming. The isolation of fungi, their 
cultivation, the extraction, isolation and identification of isolates take a great deal of time, 
especially when working with a large number of samples. The use of automation, robotics 
and on-line analyses has increased throughput significantly. This is however not feasible in 
academic institutions. Indeed, some experiments cannot be shortened for fear of lack of 
accuracy, but advances in biotechnology (fermentation, bioinformatics), molecular biology 
and chemistry (structure elucidation) have significantly decreased turnaround time. It is 
thus essential to prioritise extracts. This can be done using simple bioassays in combination 
with chemical screenings. However once again, collaboration between microbiologists, 
biochemists and chemists is essential. 
Clearly there needs to be a sustained effort to maintain integration in the marine 
biotechnology /natural products field if it is to be successful. Media optimisation and the 
physical culture conditions are crucial aspects but are often ignored by natural product 
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chemists. If the natural products indush'Y is to evolve and to flourish as a means to drug 
discovery, especially in the face of molecular biology; synthetic and combinatorial chemistry; 
and bioinformatics, then researchers in this field need to become familiar with all aspects of 
chemistry and biology. 
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APPENDIX A: MEDIA AND REAGENTS 
1.1. 1 % Agarose Gel 
Agarose 
TBE buffer (lX) 
EtBr (10mg/mL) 
1.0g 
100mL 
3.0/lL 
1.2. Ethidium bromide 110mg/mL) 
EtBr 1.0g 
Distilled H20 100mL 
The solution was stored at 4°C in a dark bottle. 
1.3. Gel Loading Buffer 
Bromophenol Blue 
Xylene cyanol 
Sucrose 
Distilled H20 
1.4. TBE Buffer (lOX) (pH=8) 
Tris-HCl 
Borric acid 
EDTA 
Distilled H20 
Dilute to 0.5X TBE for use 
1.5. YPG isolation agar 
Yeast extract 
Peptone 
Glucose 
Agar 
Seawater 
Penicillin 
Streptomycin 
0.025g 
0.025g 
4.0g 
10mL 
108g 
55g 
93g 
1000mL 
5g/L 
5g/L 
10g/L 
17g/L 
1000mL 
75mg/L 
75mg/L 
Glucose was autoclaved separately and then and added to the rest of the medium. The 
antibiotics were added to the sterile medium by filter sterilisation using 0.22/lM acetate filter . 
1.6. SW A isolation agar 
Agar 
Seawater 
Penicillin 
Streptomycin 
17g/L 
1000mL 
75mg/L 
75mg/L 
The antibiotics were added to the sterile medium by filter sterilisation using 0.22/lm acetate 
filter . 
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1.7. YPG basal medium 
Yeast extract 
Glucose 
Peptone 
Seawater 
1.8. Universal Buffer 
Sg/L 
10g/L 
Sg/L 
1000mL 
Citric acid 6g 
KH2PO. 3.9g 
Boric acid 1.7g 
Diethyl barbuturic acid S.3g 
H20 1000mL 
Adjusted using NaOH and HC!. 
1.9. Vitamin solution (Atlas, 1993) 
Thiamine 
Riboflavin 
Pyroxidine HCl 
Calcium pantothenate 
Nicotinic acid 
Biotin 
Folic acid 
p-amino benzoic acid 
H20 
O.OSg 
O.OSg 
O.OSg 
O.OSg 
O.OSg 
O.Olg 
O.Olg 
O.Olg 
100mL 
Appendices 
1.10. Universal buffer - Nitrogen free (TeoreII and Stenhagen, 1938) 
Na2HPO, 
Citric acid 
Boric acid 
1M NaOH 
H20 
7.0Sg 
7g 
3.S4g 
243mL 
1000mL 
1.11. Nutrient Agar for marine microbes 
Nutrient broth 
Agar 
Sea water 
16g/L 
lSg/L 
1000mL 
1.12. Nutrient agar for human pathogens 
Nutrient broth 
Agar 
ddH20 
16g/L 
lSg/L 
1000mL 
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1.13. Somogyi Nelson Glucose assays 
Alkaline Copper Tartrate Solution: 
CuS04.5H20 (2g), Na2C0 3 (12g), NaK tartrate (Bg) and Na2S04 (90g). 
Nelson's Aresenomolybdate Reagent: 
Dissolve 25g [(NH,)6M0 70 24.4H20 j in 450mL water. Add 21mL concentrated H2S04. Add 3g 
Na2HASO,.7H20. Make up to 500mL. Make up fresh and store for 24 hours before use. 
Standard curve: 
Made up Img/ mL stock solution of glucose 
Prepared the following in duplicates: 
Tube no. 1 2 3 
Standard (mL) 0.05 0.1 0.15 
Water (mL) 5.95 5.9 5.B5 
Cu reagent (mL) 1 
Heat on water bath at 70'C 
Aresenomolybdate (mL) I 1 
Leave to stand for 5 minutes 
Read absorbance at 510nm 
Glucose concentration 6.25 12.5 IB.75 
(~ g/ mL) 
Test sol ti u on: 
Tube 1 I 
Volume of test solution O.lmL 
(mL) 
Water(mL) 5.9mL 
Cu reagent(mL) ImL 
Heat on water bath at 70'C for 20 minutes 
Arsenomolybdate(mL) ImL 
Leave to stand for 5 minutes 
Read absorbance at 510nm 
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4 5 
0.2 0.25 
5.B 5.75 
25 31.25 
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1.14. Anticancer Assays 
Cell cuI ture 
Cells were routinely maintained at 37°C, 5% C02. WHCOl cells (an oesophageal cancer cell 
line) were cultured in DMEM supplemented with 10% fetal calf serum, 100D/mJ penicillin 
and lOOllg/mJ streptomycin. ME180 (ATCC #HTB-33) cells (a cervical cancer cell line) were 
maintained in McCoy's SA supplemented with 10% fetal calf serum, 100D / mJ penicillin, and 
lOOllg/ mJ streptomycin. 
Crystal Violet Assay 
Cells were rinsed and lifted with trypsin. They were then neutralised with an equal volume 
of media and counted using a haemocytometer. An appropriate volume of cell suspension 
was spun down at 10000rpm for 5 minutes, supernatant removed, and resuspended at 1 000 
celis/90IlI. Cells were plated in CeliStar 96 well plates, 90IlI/well (4 wells for each 
compound), and incubated at 37°C, 5% CO2 for 24 hours. Compounds were added in 10111 to 
a final concentration of 1, 10 and 50llg/mJ, with solvent (DMSO) at 0.2%. Following 48 
hours incubation, observations of cell number and morphology were made, and the plates 
were then processed for staining. Media was discarded, the plates allowed to drain, and 
100111 absolute methanol applied to each well for 10 minutes . Methanol was discarded and 
replaced with staining solution (1 % crystal violet, 50% methanol) for 20 minutes. Plates 
were rinsed with dH20, and 100111 dH20 added to each well for 1 hour. dH20 was discarded 
and replaced with a further 100111 dH20. Plates were read at 595nm on an Anthos microtitre 
plate reader 2001. 
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APPENDIX B: PRESERVATION OF FUNGI 
Preservation methods were carried out as described by Monhaghan et al. 1999. 
Preservation in dH20 
Plugs of mycelia grown on YPG agar were cut out and transferred to eppendorfs containing 
lrnL sterile dH20. The vials were stored at 4°C. 
1. Preservation with Mineral Oil 
The fungus was cultivated on agar slants until a vigorous colony had developed. Thereafter 
sterile mineral oil was added to cover the entire surface (upright) and stored at 4°C. 
2. Preservation on Filter Paper 
Pieces of agar containing fruiting bodies were placed on sterile filter paper in a Petri dish, 
dried in a dessicator, under vacuum and stored at 4°C. 
3. Cl'yopreservation 
YPG agar plugs of RUCOI0l were added to eppendorfs containing ImL of 10% 
glycerol/YPG broth. The eppendorfs were frozen with N2 and stored at -70°C. 
4. Preservation in Liquid Nitrogen 
A suspension of spores and mycelia were added to eppendorfs containing 10% glycerol YPG 
broth. The eppendorfs were frozen and stored at -70°C. 
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